[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 934
1. Kelly TG, Shattuck TM, Reyes-Mugica M, Stewart AF, Simonds WF, Udelsman R, Arnold A, Carpenter TO: Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res; 2006 Oct;21(10):1666-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Familial hyperparathyroid syndromes involving mutations of HRPT2 (also CDC73), a tumor suppressor, are important to identify because the relatively high incidence of parathyroid malignancy associated with such mutations warrants a specific surveillance strategy.
  • However, there is a dearth of reports describing experience with surveillance and early detection informed by genetic insight into this disorder.
  • INTRODUCTION: Familial isolated hyperparathyroidism (FIHP) is a rare cause of parathyroid (PT) tumors without other neoplasms or endocrinopathies.
  • Aggressive histological features of the boy's tumor included fibrous trabeculae, mitoses, and microscopic capsular infiltration.
  • Ultrasound and MRI identified a newly enlarged right superior PT gland but indicated no recurrent disease in the left neck.
  • Histologic features typical of a benign adenoma were evident after surgical extirpation of the gland.
  • The initial tumor manifested the expected germline HRPT2 mutation, plus a distinct somatic frameshift mutation, consistent with the Knudson "two hit" concept of biallelic inactivation of a classic tumor suppressor gene.
  • This information can be used in diagnostic and management considerations, leading to early detection and removal of potentially malignant parathyroid tumors.
  • [MeSH-major] Adenoma / diagnosis. Carcinoma / diagnosis. Germ-Line Mutation. Hyperparathyroidism, Primary / genetics. Parathyroid Neoplasms / diagnosis. Tumor Suppressor Proteins / genetics

  • Genetic Alliance. consumer health - Parathyroid carcinoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16995822.001).
  • [ISSN] 0884-0431
  • [Journal-full-title] Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • [ISO-abbreviation] J. Bone Miner. Res.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / K24-HD01288; United States / NCRR NIH HHS / RR / M01-RR000125
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CDC73 protein, human; 0 / Tumor Suppressor Proteins
  •  go-up   go-down


2. Türköz HK, Oksüz H, Yurdakul Z, Ozcan D: Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma. Endocr Pathol; 2008;19(2):92-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Galectin-3 expression in tumor progression and metastasis of papillary thyroid carcinoma.
  • Galectin-3 expression has been evaluated in various malignant neoplasms to determine its effectiveness in differential diagnosis from benign lesions and its effects on carcinogenesis.
  • We studied the presence of galectin-3 expression immunohistochemically and its relation with tumor invasiveness and lymph node metastasis in 89 cases of papillary carcinoma of the thyroid.
  • Degree of galectin-3 overexpression was also lower in larger tumors (P = 0.009).
  • Additionally, a decreased level of galectin-3 overexpression was observed at the invasive edges of the tumors (P = 0.001).
  • Galectin-3 overexpression is more profound in early stages of papillary carcinoma, and its expression intensity decreases during tumor progression.
  • This finding is consistent with roles for galectin-3 in cell adhesion to other tumor cells and the matrix.
  • [MeSH-minor] Adult. Aged. Aging / pathology. Biomarkers, Tumor. Disease Progression. Female. Humans. Immunohistochemistry. Lymphatic Metastasis / pathology. Male. Middle Aged. Neoplasm Invasiveness / pathology. Neoplasm Metastasis / pathology. Paraffin Embedding. Retrospective Studies. Thyroidectomy

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Oncol. 1998 Jun;12(6):1287-90 [9592187.001]
  • [Cites] J Pathol. 1996 May;179(1):43-8 [8691344.001]
  • [Cites] Cell Mol Biol Lett. 2004;9(2):305-28 [15213811.001]
  • [Cites] Eur J Endocrinol. 2003 Nov;149(5):449-53 [14585093.001]
  • [Cites] Head Neck. 2005 Dec;27(12):1049-55 [16155918.001]
  • [Cites] Hum Pathol. 2000 Apr;31(4):428-33 [10821488.001]
  • [Cites] Int J Oncol. 1999 Jul;15(1):143-8 [10375607.001]
  • [Cites] Int J Oncol. 2001 Apr;18(4):787-92 [11251175.001]
  • [Cites] Am J Pathol. 2002 Mar;160(3):1069-75 [11891203.001]
  • [Cites] Am J Clin Pathol. 2006 Mar;125(3):399-406 [16613343.001]
  • [Cites] Neuropathol Appl Neurobiol. 1999 Aug;25(4):319-30 [10476049.001]
  • [Cites] Histopathology. 2006 Jun;48(7):795-800 [16722927.001]
  • [Cites] Mod Pathol. 2005 Jan;18(1):48-57 [15272279.001]
  • [Cites] Exp Cell Res. 1998 Dec 15;245(2):294-302 [9851870.001]
  • [Cites] Acta Cytol. 2006 Sep-Oct;50(5):518-28 [17017437.001]
  • [Cites] J Natl Cancer Inst. 1992 Aug 5;84(15):1161-9 [1386115.001]
  • [Cites] Biochem Soc Trans. 1992 May;20(2):269-74 [1397610.001]
  • [Cites] Int J Cancer. 2000 Feb 15;85(4):545-54 [10699929.001]
  • [Cites] Gastroenterology. 1997 Dec;113(6):1906-15 [9394730.001]
  • [Cites] Cancer Res. 1996 Oct 1;56(19):4530-4 [8813152.001]
  • [Cites] Cancer Res. 1998 Jul 15;58(14):3015-20 [9679965.001]
  • (PMID = 18581271.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Galectin 3
  •  go-up   go-down


3. Bayar MA, Erdem Y, Gokcek C, Koktekir E, Kilic C, Yasitli U, Tekiner A: Giant cell reparative granuloma of the axis. Turk Neurosurg; 2009 Oct;19(4):423-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Giant cell reparative granuloma (GCRG) is a rare, benign fibroosseous lesion.
  • A 35-year-old man was admitted to our clinic with the complaint of pain at his neck.
  • We filled the tumor cavity with a bone graft and the patient was discharged with a halo brace without any neurological deficits.
  • The follow-up CT revealed one year after the surgery showed sclerosis at the tumor site.
  • The etiopathogenesis of GCRG is still controversial and the differential diagnosis, especially from giant cell tumor of bone is quite difficult.

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Spine Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19847766.001).
  • [ISSN] 1019-5149
  • [Journal-full-title] Turkish neurosurgery
  • [ISO-abbreviation] Turk Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


Advertisement
4. Aitasalo KM, Peltola MJ: Bioactive glass hydroxyapatite in fronto-orbital defect reconstruction. Plast Reconstr Surg; 2007 Dec;120(7):1963-72; discussion 1973-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, the clinical outcome of bioactive glass and hydroxyapatite in head and neck surgery was evaluated.
  • METHODS: In a retrospective series of 150 patients, 62 patients underwent reconstruction with frontal sinus obliteration after chronic frontal sinusitis, 65 patients were operated on for fronto-orbital traumas, and 23 patients underwent reconstruction after fronto-orbital tumor resections.
  • All 12 benign tumor patients and six of 11 malignant tumor patients survived during a follow-up of 3 years.
  • Two of the 23 (9 percent) complicated tumor and trauma patients underwent reoperation because of a local mucocele.
  • CONCLUSIONS: Treatment of severe head and neck defects with biomaterial is a suitable alternative to conventional methods.

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. HYDROXYAPATITE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18090760.001).
  • [ISSN] 1529-4242
  • [Journal-full-title] Plastic and reconstructive surgery
  • [ISO-abbreviation] Plast. Reconstr. Surg.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bone Substitutes; 91D9GV0Z28 / Durapatite
  •  go-up   go-down


5. Giblin E, Lynn D, Mortman K: Cervical hibernoma demonstrating uptake on Tc-99m lymphoscintigraphy. Clin Nucl Med; 2006 Nov;31(11):694-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A hibernoma is an uncommon, benign tumor composed of brown adipose tissue.
  • It is a rare but documented cause of neck masses.
  • These tumors are by definition benign entities but, given their propensity for growth over time, they require complete extirpation to prevent recurrence.
  • [MeSH-major] Head and Neck Neoplasms / metabolism. Head and Neck Neoplasms / radionuclide imaging. Lipoma / metabolism. Lipoma / radionuclide imaging. Technetium Tc 99m Sulfur Colloid / pharmacokinetics

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17053387.001).
  • [ISSN] 0363-9762
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 556Q0P6PB1 / Technetium Tc 99m Sulfur Colloid
  •  go-up   go-down


6. Dickson PV, Davidoff AM: Malignant neoplasms of the head and neck. Semin Pediatr Surg; 2006 May;15(2):92-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant neoplasms of the head and neck.
  • Head and neck masses represent a common clinical entity in children.
  • The differential diagnosis is broad, and expeditiously distinguishing benign from malignant masses is critical for instituting a timely multidisciplinary approach to the management of malignant lesions.
  • Neoplasms of the head and neck account for approximately 5% of all childhood malignancies.
  • A diagnosis of malignancy may represent a primary tumor or metastatic foci to cervical nodes.
  • In this review, we discuss the general approach to evaluating suspicious masses and adenopathy in the head and neck region and summarize the most common malignant neoplasms of the head and neck with regard to their incidence, clinical presentation, diagnostic evaluation, staging, and management.
  • Thyroid, parathyroid, and salivary gland tumors are discussed elsewhere in this issue of Seminars in Pediatric Surgery.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Head and Neck Neoplasms / therapy
  • [MeSH-minor] Child. Diagnosis, Differential. Humans. Lymph Nodes / anatomy & histology. Lymphatic Diseases / diagnosis. Lymphatic Diseases / therapy. Lymphoma / diagnosis. Lymphoma / therapy. Neck. Neuroblastoma / diagnosis. Neuroblastoma / therapy. Rhabdomyosarcoma / diagnosis. Rhabdomyosarcoma / therapy

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16616312.001).
  • [ISSN] 1055-8586
  • [Journal-full-title] Seminars in pediatric surgery
  • [ISO-abbreviation] Semin. Pediatr. Surg.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA 21765
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 24
  •  go-up   go-down


7. Park KT, Ahn Y, Kim KH, Kwon TK: Schwannoma mimicking laryngocele. Clin Exp Otorhinolaryngol; 2010 Sep;3(3):166-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A schwannoma of the larynx is a rare benign tumor that usually presents as a submucosal mass in the pyriform sinus and the aryepiglottic space, and this type of schwannoma constitutes a diagnostic and therapeutic challenge for otolaryngologists.
  • We discuss the clinical and imaging findings and the management of this rare neoplasm with focusing on the differential diagnosis of laryngeal schwannoma and laryngocele.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20978630.001).
  • [ISSN] 2005-0720
  • [Journal-full-title] Clinical and experimental otorhinolaryngology
  • [ISO-abbreviation] Clin Exp Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2958503
  • [Keywords] NOTNLM ; Larynx / Neurogenic tumor / Schwannoma
  •  go-up   go-down


8. Lewis JS, Ritter JH, El-Mofty S: Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1. Mod Pathol; 2005 Nov;18(11):1471-81
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1.
  • Sarcomatoid carcinomas are rare malignancies which represent poorly differentiated epithelial tumors that may be difficult to recognize as such.
  • We sought to assess the diagnostic utility of several immunohistochemical markers of epithelial differentiation including p63, MOC-31, and thyroid transcription factor-1 on sarcomatoid carcinomas of the head and neck (19 cases; 'spindle cell carcinomas'), lung (19 cases), and urinary bladder (11 cases).
  • Staining for p63 showed the greatest diagnostic utility, positive in 63, 50, and 36% of head and neck, lung, and urinary bladder sarcomatoid carcinomas, respectively. p63 stains were positive in many cases where immunohistochemistry was negative for both pan-cytokeratin and epithelial membrane antigen.
  • All three alternative markers were quite specific for epithelial differentiation, each staining less than 10% of the control group of 73 various primary and metastatic sarcomas, melanomas, and benign spindle cell lesions.
  • [MeSH-major] Biomarkers, Tumor / analysis. Carcinoma / diagnosis. Head and Neck Neoplasms / diagnosis. Lung Neoplasms / diagnosis. Urinary Bladder Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Modern Pathology (2005) 18, 1471-1481. doi:10.1038/modpathol.3800451; published online 10 June 2005.
  • (PMID = 15976812.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CKAP4 protein, human; 0 / Membrane Glycoproteins; 0 / Membrane Proteins; 0 / Mucin-1; 0 / Nuclear Proteins; 0 / Transcription Factors; 0 / thyroid nuclear factor 1; 68238-35-7 / Keratins
  •  go-up   go-down


9. Kang SW, Jeong JJ, Yun JS, Sung TY, Lee SC, Lee YS, Nam KH, Chang HS, Chung WY, Park CS: Gasless endoscopic thyroidectomy using trans-axillary approach; surgical outcome of 581 patients. Endocr J; 2009;56(3):361-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • 2007 (actual operation period was 50 months), 581 patients with thyroid tumors underwent gasless endoscopic thyroidectomy via an axillary approach.
  • RESULTS: Among the 581 patients, 171 patients had benign tumor and 410 patients had malignant tumor.
  • The operating time and the length of post-operative hospital stay were 129.4+/-51.3 minutes, 3.3+/-1.7 days in benign tumor, and 135.5+/-47 minutes, 3.4+/-0.9 days in malignant tumors, respectively.
  • The tumor size was 2.7+/-1.2 cm in benign tumor and 0.78+/-0.5 cm in malignancy.
  • Central compartment lymph node metastasis was found in 112 (27.3%) patients and lateral neck lymph node metastasis in 13 (3.1%) patients.
  • Endoscopic thyroid surgery has become a new treatment modality for the patients with benign tumors and can be an effective alternative treatment for the selected patients with thyroid cancer.


10. Linecker A, Kermer C, Sulzbacher I, Angelberger P, Kletter K, Dudczak R, Ewers R, Becherer A: Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival. Nuklearmedizin; 2008;47(2):80-5; quiz N12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Uptake of (18)F-FLT and (18)F-FDG in primary head and neck cancer correlates with survival.
  • The aim of the study was to determine the practicability of (18)F-FLT in tumours of the head and neck area in terms of visualization, a possible correlation between FLT uptake and proliferation fraction as determined by Ki-67 immunostaining, and if tumoural FLT-uptake has a prognostic meaning, as determined by a correlation to patient survival time.
  • PATIENTS, METHODS: 20 patients with previously untreated lesions of the head and neck area, which were clinically highly suspicious to be malignant, underwent PET scans with (18)F-FLT and (18)F-FDG, a CT of the head and neck area, and a biopsy.
  • Tumour tracer uptake was determined by standardized uptake value (SUV) normalized to body weight and /non-tumor ratios (T/N). (18)F-FDG and (18)F-FLT uptake were compared with histopathologic and immunohistochemical results.
  • RESULTS: 19 patients had malignant tumours; one patient had a benign cystadenoma (so called Warthin's tumour) of the parotid gland.
  • One negative lesion turned out to be a malignant T1 stage squamous cell carcinoma in both PET scans, the Warthin's tumour was false positive with (18)F-FDG but showed only faint uptake with (18)F-FLT, resulting in a sensitivity of 95 % for both tracers.
  • CONCLUSION: In head and neck cancer in the primary setting (18)F-FLT does not provide additional visual information in comparison to (18)F-FDG.(18)F-FLT uptake is inversely correlated with patient survival, as well as (18)F-FDG.
  • [MeSH-major] Dideoxynucleosides. Fluorodeoxyglucose F18 / pharmacokinetics. Head and Neck Neoplasms / mortality. Head and Neck Neoplasms / radionuclide imaging. Radioisotopes

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18392317.001).
  • [ISSN] 0029-5566
  • [Journal-full-title] Nuklearmedizin. Nuclear medicine
  • [ISO-abbreviation] Nuklearmedizin
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Dideoxynucleosides; 0 / Fluorine Radioisotopes; 0 / Radioisotopes; 0Z5B2CJX4D / Fluorodeoxyglucose F18; PG53R0DWDQ / alovudine
  •  go-up   go-down


11. Mahalingam M, Alter JN, Bhawan J: Multiple cellular neurothekeomas--a case report and review on the role of immunohistochemistry as a histologic adjunct. J Cutan Pathol; 2006 Jan;33(1):51-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Cellular neurothekeoma is a relatively rare, benign cutaneous neoplasm, which usually presents as a solitary papule or nodule involving the head and neck area of young adults.
  • METHODS: We report a 30-year-old, otherwise healthy, male who presented with multiple neurothekeomas (15) in the head and neck area over a period of 12 years.
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Biopsy. Humans. Male. Neoplasm Recurrence, Local

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16441413.001).
  • [ISSN] 0303-6987
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


12. Ondik MP, Preston T, Towfighi J, Isaacson JE: Unilateral congenital facial nerve paralysis secondary to a benign epithelioid peripheral nerve sheath tumor. Otol Neurotol; 2007 Dec;28(8):1091-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unilateral congenital facial nerve paralysis secondary to a benign epithelioid peripheral nerve sheath tumor.
  • OBJECTIVE: A benign epithelioid peripheral nerve sheath tumor is described in the setting of congenital facial nerve (FN) paralysis.
  • INTERVENTIONS: Auditory brainstem evoked potential study, gadolinium-enhanced magnetic resonance imaging, temporal bone computed tomography, and transmastoid FN decompression with tumor resection.
  • MAIN OUTCOME MEASURES: Follow-up for tumor recurrence and postoperative FN function.
  • RESULTS: The child underwent a transmastoid FN exploration with resection of a 0.6-cm spherical tumor analyzed to be a benign epithelioid peripheral nerve sheath tumor.
  • CONCLUSION: Benign epithelioid peripheral nerve sheath tumor can cause congenital facial nerve palsy.

  • Genetic Alliance. consumer health - paralysis.
  • Hazardous Substances Data Bank. GADOLINIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18084823.001).
  • [ISSN] 1531-7129
  • [Journal-full-title] Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
  • [ISO-abbreviation] Otol. Neurotol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] AU0V1LM3JT / Gadolinium
  •  go-up   go-down


13. Ganly I, Gross ND, Patel SG, Bilsky MH, Shah JP, Kraus DH: Outcome of craniofacial resection in patients 70 years of age and older. Head Neck; 2007 Feb;29(2):89-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thirty-five patients had a malignant tumor and 1 patient a benign tumor; 15 (42%) had high-grade, 17 (47%) intermediate-grade, and 4 (11%) low-grade pathology.
  • [MeSH-minor] Age Factors. Aged. Aged, 80 and over. Carcinoma / mortality. Carcinoma / pathology. Carcinoma / surgery. Cranial Fossa, Anterior / surgery. Cranial Fossa, Middle / surgery. Databases as Topic. Esthesioneuroblastoma, Olfactory / mortality. Esthesioneuroblastoma, Olfactory / pathology. Esthesioneuroblastoma, Olfactory / surgery. Female. Follow-Up Studies. Humans. Male. Melanoma / mortality. Melanoma / pathology. Melanoma / surgery. Neoplasm Recurrence, Local. Prospective Studies. Surgical Flaps. Survival Analysis


14. Nuyens M, Zbären P, Seifert E: Endoscopic resection of laryngeal and tracheal lesions using the microdebrider. Acta Otolaryngol; 2006 Apr;126(4):402-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In 29 cases a benign laryngeal lesion was removed endoscopically.
  • In four patients debulking of a malignant obstructive endolaryngeal tumor was performed in order to avoid a tracheotomy.

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Tracheal Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16608793.001).
  • [ISSN] 0001-6489
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Norway
  •  go-up   go-down


15. Sands NB, Karls S, Rivera J, Tamilia M, Hier MP, Black MJ, Gologan O, Payne RJ: Preoperative serum thyroglobulin as an adjunct to fine-needle aspiration in predicting well-differentiated thyroid cancer. J Otolaryngol Head Neck Surg; 2010 Dec;39(6):669-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In addition, mean preoperative Tg levels were found to be significantly higher in patients with WDTC compared to those with benign pathology (223 vs 53 microg/L, p = .007).
  • [MeSH-major] Biomarkers, Tumor / blood. Biopsy, Fine-Needle. Thyroglobulin / blood. Thyroid Neoplasms / blood. Thyroid Neoplasms / pathology

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • Hazardous Substances Data Bank. THYROGLOBULIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21144363.001).
  • [ISSN] 1916-0216
  • [Journal-full-title] Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale
  • [ISO-abbreviation] J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 9010-34-8 / Thyroglobulin
  •  go-up   go-down


16. Durgun Y, Firat C, Miman MC, Kirimlioglu H: A rare benign laryngeal tumor: angiomyolipoma. J Craniofac Surg; 2010 Nov;21(6):1956-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A rare benign laryngeal tumor: angiomyolipoma.
  • Angiomyolipoma is a mesenchymal neoplasm containing adipose tissue, blood vessels, and smooth muscle fibers.
  • Arising most frequently in the kidney, the tumor may exceptionally be at the head and neck region.
  • The tumor was removed by an endolaryngeal approach.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21119467.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Unlü Y, Becit N, Ceviz M, Koçak H: Management of carotid body tumors and familial paragangliomas: review of 30 years' experience. Ann Vasc Surg; 2009 Sep-Oct;23(5):616-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of carotid body tumors and familial paragangliomas: review of 30 years' experience.
  • BACKGROUND: Carotid body tumors (CBTs), especially familial paragangliomas, are rare benign neoplasms, accounting for <0.5% of all tumors; and they are the most common extra-adrenal paraganglioma.
  • A mass in the neck was the common symptom in all patients.
  • UltraCision was used in five patients for tumor resection; the surgical results of these patients were excellent (easy dissection, minimal hemorrhage and time operation).
  • One case of hypoglossal paralysis and one benign recurrence were detected.
  • [MeSH-major] Carotid Body Tumor / surgery. Paraganglioma, Extra-Adrenal / surgery. Vascular Surgical Procedures

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19747612.001).
  • [ISSN] 1615-5947
  • [Journal-full-title] Annals of vascular surgery
  • [ISO-abbreviation] Ann Vasc Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Papagelopoulos PJ, Mavrogenis AF, Benetos IS, Papaparaskeva K, Galanis EC, Soucacos PN: Ewing's sarcoma of the hip presenting as a benign cystic lesion. J Surg Orthop Adv; 2007;16(2):84-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ewing's sarcoma of the hip presenting as a benign cystic lesion.
  • A 14-year-old girl with a Ewing's sarcoma of the left femoral head and neck is presented.
  • The imaging features mimicked a benign cystic lesion.
  • The patient was treated with chemotherapy, wide tumor resection, and proximal femoral reconstruction using an allograft-prosthesis composite.

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Surg Orthop Adv. 2007 Winter;16(4):207; author reply 207 [18053405.001]
  • (PMID = 17592716.001).
  • [ISSN] 1548-825X
  • [Journal-full-title] Journal of surgical orthopaedic advances
  • [ISO-abbreviation] J Surg Orthop Adv
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / EWS-FLI fusion protein; 0 / Oncogene Proteins, Fusion; 0 / Proto-Oncogene Protein c-fli-1; 0 / RNA-Binding Protein EWS
  •  go-up   go-down


19. Liutkeviciūte-Navickiene J, Mordas A, Simkute S, Bloznelyte-Plesniene L: [Fluorescence diagnostics of skin tumors using 5-aminolevulinic acid and its methyl ester]. Medicina (Kaunas); 2009;45(12):937-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Fluorescence diagnostics of skin tumors using 5-aminolevulinic acid and its methyl ester].
  • OBJECTIVE: The incidence of malignant skin tumors is rapidly increasing.
  • Early diagnosis, determining the margins of the tumor, is extremely important to achieve good treatment results.
  • The study aimed to compare the effectiveness of topical 5-aminolevulinic acid and methyl-aminolevulinate in determining the exact margins of skin tumors.
  • MATERIALS AND METHODS: Fluorescence measurements were performed in 126 patients with malignant, premalignant, and benign skin lesions for detection of the margins of squamous cell carcinoma and basal cell carcinoma.
  • This method is applicable for detecting early superficial tumors, margins of tumors, and follow-up after therapy.
  • [MeSH-major] Aminolevulinic Acid / analogs & derivatives. Carcinoma, Basal Cell / diagnosis. Carcinoma, Squamous Cell / diagnosis. Fluorescence. Head and Neck Neoplasms / diagnosis. Photosensitizing Agents. Precancerous Conditions / diagnosis. Protoporphyrins. Skin Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20173396.001).
  • [ISSN] 1648-9144
  • [Journal-full-title] Medicina (Kaunas, Lithuania)
  • [ISO-abbreviation] Medicina (Kaunas)
  • [Language] lit
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Lithuania
  • [Chemical-registry-number] 0 / Esters; 0 / Photosensitizing Agents; 0 / Protoporphyrins; 0 / methyl 5-aminolevulinate; 553-12-8 / protoporphyrin IX; 88755TAZ87 / Aminolevulinic Acid
  •  go-up   go-down


20. Namyslowski G, Scierski W, Misiolek M, Urbaniec N, Lange D: Huge retropharyngeal lipoma causing obstructive sleep apnea: A case report. Eur Arch Otorhinolaryngol; 2006 Aug;263(8):738-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lipoma of the retropharyngeal space is a very rare benign tumor often causing unspecific clinical symptoms.
  • The radiological imaging techniques (CT and MRI) can provide adequate information with regard to the composition and extension of the tumor, although final histological confirmation is essential.
  • The tumor was removed via transcervical approach with complete amelioration of symptoms.

  • Genetic Alliance. consumer health - Sleep Apnea.
  • MedlinePlus Health Information. consumer health - Throat Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Laryngorhinootologie. 2005 Jan;84(1):51-3 [15647978.001]
  • [Cites] J Otolaryngol. 1998 Dec;27(6):363-6 [9857324.001]
  • [Cites] Laryngoscope. 2002 Sep;112(9):1603-5 [12352671.001]
  • [Cites] Otolaryngol Head Neck Surg. 1996 Apr;114(4):628-30 [8643275.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2001 Nov;258(9):458-9 [11769991.001]
  • [Cites] J Oral Maxillofac Surg. 1998 Aug;56(8):1003-4 [9710200.001]
  • (PMID = 16673079.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


21. Alix T, Labbé D, Caquant L, Comoz F, Compère JF, Bénateau H: [Management of whole-scalp tumour: the Poncet-Spiegler cylindroma or turban tumour]. Rev Stomatol Chir Maxillofac; 2009 Apr;110(2):109-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Management of whole-scalp tumour: the Poncet-Spiegler cylindroma or turban tumour].
  • INTRODUCTION: The Poncet-Spiegler cylindroma (PSC) is a benign annexal cutaneous tumor which preferentially develops on the scalp, neck, or forehead.
  • When the scalp is completely involved, it presents as a "turban tumor".
  • Treatment is surgery and may be difficult when the tumor is extended.
  • We report the management of turban tumor.
  • DISCUSSION: As for most tumors, management depends on the size of the PSC.
  • In case of turban tumor, total scalp exeresis and secondary reconstruction with a skin graft is recommended.
  • [MeSH-major] Carcinoma, Adenoid Cystic / surgery. Head and Neck Neoplasms / surgery. Scalp / surgery. Skin Neoplasms / surgery
  • [MeSH-minor] Adult. Esthetics. Female. Follow-Up Studies. Humans. Neoplasm Recurrence, Local / surgery. Reconstructive Surgical Procedures. Skin Transplantation / methods

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19328506.001).
  • [ISSN] 1776-257X
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


22. Barut F, Onak Kandemir N, Bektas S, Bahadir B, Keser S, Ozdamar SO: Universal markers of thyroid malignancies: galectin-3, HBME-1, and cytokeratin-19. Endocr Pathol; 2010 Jun;21(2):80-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This study has been carried on to evaluate the role of immunohistochemical markers including galectin-3, Hector Battifora mesothelial cell-1 (HBME-1), and cytokeratin-19 in the diagnosis and differential diagnosis of benign and malignant thyroid lesions.
  • The use of galectin-3, HBME-1, and cytokeratin-19 may provide significant contributions in the differential diagnosis of malignant thyroid tumors.
  • Although focal galectin-3, HBME-1, and cytokeratin-19 expression may be encountered in benign lesions, diffuse positive reactions for these three markers are characteristic of malignant lesions.
  • [MeSH-major] Biomarkers, Tumor / analysis. Galectin 3 / biosynthesis. Keratin-19 / biosynthesis. Thyroid Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Endocr Pathol. 2002 Fall;13(3):207-11 [12446919.001]
  • [Cites] Endocr J. 2003 Apr;50(2):173-7 [12803237.001]
  • [Cites] Am J Clin Pathol. 2004 Oct;122(4):524-31 [15487449.001]
  • [Cites] Eur J Endocrinol. 2003 Nov;149(5):449-53 [14585093.001]
  • [Cites] Endocr Relat Cancer. 2005 Jun;12(2):305-17 [15947105.001]
  • [Cites] Histopathology. 2005 Oct;47(4):391-401 [16178894.001]
  • [Cites] Diagn Pathol. 2008 Feb 06;3:5 [18254952.001]
  • [Cites] Mod Pathol. 2001 Apr;14(4):338-42 [11301350.001]
  • [Cites] Endocr Pathol. 2006 Fall;17(3):225-34 [17308359.001]
  • [Cites] Am J Clin Pathol. 1989 Nov;92(5):654-8 [2479256.001]
  • [Cites] Mod Pathol. 2006 Dec;19(12):1631-7 [16998461.001]
  • [Cites] Lancet. 2001 May 26;357(9269):1644-50 [11425367.001]
  • [Cites] Singapore Med J. 2008 Apr;49(4):333-8 [18418527.001]
  • [Cites] Histopathology. 2002 Sep;41(3):236-43 [12207785.001]
  • [Cites] Pathology. 2005 Aug;37(4):296-8 [16194828.001]
  • [Cites] Hum Pathol. 2000 Apr;31(4):428-33 [10821488.001]
  • [Cites] Histopathology. 2005 Aug;47(2):209-14 [16045783.001]
  • [Cites] Ann Surg Oncol. 2008 Oct;15(10):2811-26 [18612701.001]
  • [Cites] Mod Pathol. 2005 Apr;18(4):541-6 [15529186.001]
  • [Cites] J Korean Med Sci. 2005 Oct;20(5):853-9 [16224162.001]
  • [Cites] Virchows Arch. 1997 Mar;430(3):239-45 [9099982.001]
  • [Cites] Histopathology. 2004 Jul;45(1):39-46 [15228442.001]
  • [Cites] Endocr Pathol. 2008 Summer;19(2):92-6 [18581271.001]
  • [Cites] Am J Clin Pathol. 2006 Nov;126(5):700-8 [17050067.001]
  • [Cites] Histopathology. 2006 Jun;48(7):795-800 [16722927.001]
  • [Cites] Mod Pathol. 2005 Jan;18(1):48-57 [15272279.001]
  • [Cites] Virchows Arch. 2004 Apr;444(4):309-12 [14999471.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Oct;87(10):4792-6 [12364475.001]
  • [Cites] Cancer. 2005 Apr 25;105(2):87-95 [15742329.001]
  • [Cites] Head Neck. 2004 Nov;26(11):960-6 [15386597.001]
  • [Cites] J Korean Med Sci. 2007 Aug;22(4):621-8 [17728499.001]
  • [Cites] Cancer. 1999 Jun 1;85(11):2475-84 [10357421.001]
  • [Cites] Cancer Res. 1998 Jul 15;58(14):3015-20 [9679965.001]
  • [Cites] Ann Intern Med. 2005 Jun 7;142(11):926-31 [15941700.001]
  • (PMID = 20198455.001).
  • [ISSN] 1559-0097
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Galectin 3; 0 / HBME-1 antigen; 0 / Keratin-19
  •  go-up   go-down


23. Mebazaa A, Trabelsi S, Denguezli M, Sriha B, Belajouza C, Nouira R: Chondroid syringoma of the arm: an unusual localization. Dermatol Online J; 2006;12(1):14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chondroid syringoma (CS) is an uncommon, benign, sweat-gland tumor.
  • The usual presentation is of an asymptomatic, slowly growing mass, typically located on the head and neck region.
  • This tumor developed slowly over 8 years.
  • There was no recurrence after total excision of the tumor with a 2-year followup.
  • Surgical tumor excision remains the best therapeutic option to avoid relapses of this tumor.

  • Genetic Alliance. consumer health - Syringoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16638382.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Asari R, Niederle BE, Scheuba C, Riss P, Koperek O, Kaserer K, Niederle B: Indeterminate thyroid nodules: a challenge for the surgical strategy. Surgery; 2010 Sep;148(3):516-25
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The prognostic relevance of sex, age, tumor sizes, multifocality, thyroid function, and recurrence was analyzed in 156 consecutive patients according to the presence of malignancy and nodal metastases.
  • Comparing benign and malignant ITN, no association was found for sex (P = .17), age (P = 1.0), tumor sizes (P = .33, P = .12, P = .19 for < or =30 mm, < or =40 mm, and < or =50 mm, respectively), or thyroid function (P = .26).
  • Ipsilateral "first step central neck dissection" on the side of ITN offers the advantages of oncologically adequate resection and staging with a low morbidity, as well as avoids reoperation.
  • [MeSH-minor] Adult. Female. Humans. Laryngeal Nerves / pathology. Laryngeal Nerves / surgery. Lymph Node Excision. Male. Middle Aged. Neoplasm Metastasis / pathology. Prognosis. Prospective Studies. Recurrence. Retrospective Studies. Thyroid Function Tests. Thyroidectomy

  • MedlinePlus Health Information. consumer health - Surgery.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Mosby, Inc. All rights reserved.
  • (PMID = 20338609.001).
  • [ISSN] 1532-7361
  • [Journal-full-title] Surgery
  • [ISO-abbreviation] Surgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Irfan M, Idayu MY, Venkatesh RN: Cavernous hemangioma mimicking anterior jugular vein phlebectesia. Med J Malaysia; 2010 Mar;65(1):68-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cavernous hemangioma is a vascular tumor composed of large dilated blood vessels and containing large blood-filled spaces.
  • On the other hand, jugular phlebectasia is an abnormal benign sacculofusiform dilatation of jugular veins.
  • It should be considered as one of the differential diagnosis of neck swelling.

  • Genetic Alliance. consumer health - Hemangioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21265254.001).
  • [ISSN] 0300-5283
  • [Journal-full-title] The Medical journal of Malaysia
  • [ISO-abbreviation] Med. J. Malaysia
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Malaysia
  •  go-up   go-down


26. Phung TL, Hochman M, Mihm MC: Current knowledge of the pathogenesis of infantile hemangiomas. Arch Facial Plast Surg; 2005 Sep-Oct;7(5):319-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Infantile hemangiomas are the most common benign tumor of infancy, occurring shortly after birth in 5% to 10% of white infants.
  • Many hemangiomas are discrete, well-circumscribed masses present in the head and neck.
  • Some hemangiomas are segmental and diffuse, often involving large areas of the extremities or the head and neck.

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16172341.001).
  • [ISSN] 1521-2491
  • [Journal-full-title] Archives of facial plastic surgery
  • [ISO-abbreviation] Arch Facial Plast Surg
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / T32 HL07893
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
  • [Publication-country] United States
  • [Number-of-references] 32
  •  go-up   go-down


27. Sattar HA, Yang DL, Husain AN, Redleaf MI, Dayal VS: Multiple paragangliomata of the lungs and temporal bone. Ear Nose Throat J; 2008 Nov;87(11):E4-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report the case of a 71-year-old woman with multiple benign lung paragangliomata and a benign glomus jugulare paraganglioma in one temporal bone that mimicked a malignancy.
  • Subsequent histologic markers suggested several very slowly dividing tumors.
  • A finding of multiple lung paragangliomata should raise the suspicion of a multicentric rather than malignant tumor.
  • Before any chemotherapeutic regimen is initiated, a thorough physical examination of the head and neck should be performed, and biopsy material should be tested for markers of cell division.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19006054.001).
  • [ISSN] 1942-7522
  • [Journal-full-title] Ear, nose, & throat journal
  • [ISO-abbreviation] Ear Nose Throat J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


28. Ardigo M, Zieff J, Scope A, Gill M, Spencer P, Deng L, Marghoob AA: Dermoscopic and reflectance confocal microscope findings of trichoepithelioma. Dermatology; 2007;215(4):354-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Trichoepitheliomas (TE) are benign neoplasms of follicular differentiation.
  • RCM showed oval, darker-appearing tumor islands that contained brightly refractile material, consistent with keratin horn cysts at the center, as well as parallel bundles of highly refractile dermal collagen surrounding the tumor islands.
  • The RCM findings in TE of keratin-filled cysts in tumor islands and attachment of the tumor to follicular structures have not been previously observed in BCC, and thus may also be diagnostically helpful.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Dermoscopy / methods. Head and Neck Neoplasms / pathology. Microscopy, Confocal. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2007 S. Karger AG, Basel
  • (PMID = 17911996.001).
  • [ISSN] 1421-9832
  • [Journal-full-title] Dermatology (Basel, Switzerland)
  • [ISO-abbreviation] Dermatology (Basel)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


29. Pakdaman MN, Rochon L, Gologan O, Tamilia M, Garfield N, Hier MP, Black MJ, Payne RJ: Incidence and histopathological behavior of papillary microcarcinomas: study of 429 cases. Otolaryngol Head Neck Surg; 2008 Nov;139(5):718-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There was no significant difference in PMC incidence in patients with malignant vs benign disease.
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Cohort Studies. Female. Humans. Incidence. Male. Middle Aged. Retrospective Studies. Thyroidectomy. Tumor Burden

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18984270.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


30. McCall T, Rao G, Jensen R: Development and rapid growth of a desmoid tumor in the surgical corridor after suboccipital craniotomy for recurrent low-grade astrocytoma. J Neurooncol; 2006 Nov;80(2):167-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development and rapid growth of a desmoid tumor in the surgical corridor after suboccipital craniotomy for recurrent low-grade astrocytoma.
  • Desmoid tumors are histologically benign but locally invasive tumors that can occur in the head and neck.
  • We present the rare case of a desmoid tumor that occurred in the surgical corridor after suboccipital craniotomy for recurrent low-grade astrocytoma.
  • Histology demonstrated clear surgical margins and a tumor of low cellularity consistent with a desmoid tumor.
  • Desmoid tumors should be considered in the differential diagnosis for superficial masses occurring in the surgical bed after posterior cervical surgery.

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg. 1973 Jul;39(1):114-6 [4717135.001]
  • [Cites] Cancer. 1960 Jul-Aug;13:825-36 [14405434.001]
  • [Cites] Clin Orthop Relat Res. 2000 Jun;(375):207-13 [10853171.001]
  • [Cites] Cancer. 1999 Nov 15;86(10):2045-52 [10570430.001]
  • [Cites] Orthop Rev. 1987 Jul;16(7):481-8 [3331192.001]
  • [Cites] Acta Chir Scand. 1979;145(8):563-9 [539343.001]
  • [Cites] Arch Surg. 2001 Jan;136(1):70-9 [11146782.001]
  • [Cites] Am J Surg. 1966 Oct;112(4):615-22 [5915310.001]
  • [Cites] Tumori. 2005 Jul-Aug;91(4):325-30 [16277098.001]
  • [Cites] Neurosurgery. 1999 Oct;45(4):875-81; discussion 881-2 [10515483.001]
  • [Cites] Br J Surg. 1995 Apr;82(4):510-4 [7613897.001]
  • [Cites] Arch Surg. 1989 Feb;124(2):191-6 [2916941.001]
  • [Cites] Cancer. 1984 Nov 15;54(10):2051-5 [6488135.001]
  • [Cites] Radiology. 1977 Jul;124(1):225-6 [405711.001]
  • [Cites] Cancer. 1967 Jul;20(7):1131-40 [6027003.001]
  • [Cites] Am J Clin Pathol. 1982 Jun;77(6):674-80 [7091047.001]
  • [Cites] J Bone Joint Surg Am. 1996 Jun;78(6):848-54 [8666602.001]
  • [Cites] Surgery. 1969 Feb;65(2):241-6 [4237097.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):325-8 [8892455.001]
  • [Cites] Ann Surg. 1999 Jun;229(6):866-72; discussion 872-3 [10363901.001]
  • [Cites] Br J Surg. 2000 May;87(5):608-13 [10792318.001]
  • [Cites] J Surg Oncol. 2004 Jun 1;86(3):152-6 [15170654.001]
  • [Cites] Surgery. 1964 Sep;56:497-504 [14215706.001]
  • [Cites] Am J Surg. 1988 Oct;156(4):327-31 [3177760.001]
  • [Cites] Head Neck. 2000 Dec;22(8):814-21 [11084643.001]
  • [Cites] Am J Hum Genet. 1962 Dec;14:376-90 [13946545.001]
  • [Cites] J Bone Joint Surg Am. 1984 Dec;66(9):1369-74 [6501332.001]
  • [Cites] J Thorac Cardiovasc Surg. 1963 Aug;46:242-51 [14049009.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1983 Aug;9(8):1167-71 [6409853.001]
  • [Cites] World J Surg Oncol. 2005 Jul 21;3:49 [16042767.001]
  • [Cites] Arch Pathol. 1961 Feb;71:214-21 [13706852.001]
  • (PMID = 16645711.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Hoyoux C: [Vincristine treatment for management of alarming hemangiomas in infancy]. Rev Med Liege; 2008 Jan;63(1):14-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hemangioma is the most benign vascular tumor encountered in infancy; its incidence is 10-12% at 1 year of age.
  • [MeSH-minor] Head and Neck Neoplasms / drug therapy. Humans. Infant. Skin Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18303680.001).
  • [ISSN] 0370-629X
  • [Journal-full-title] Revue médicale de Liège
  • [ISO-abbreviation] Rev Med Liege
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Belgium
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 5J49Q6B70F / Vincristine
  • [Number-of-references] 10
  •  go-up   go-down


32. Wu YH, Wan JH, Qi YF, Xu ZG, Tang PZ, Guo J: [Cooperation management by head and neck surgery and neurosurgery for skull base tumors]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jun;44(6):475-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cooperation management by head and neck surgery and neurosurgery for skull base tumors].
  • OBJECTIVE: To present the experience and advantage of cooperation management by head and neck surgery and neurosurgery for communicating skull base tumors.
  • METHODS: A review of 54 communicating skull base tumors (benign tumor 21, malignant tumor 33) cooperation resection by head and neck surgery and neurosurgery from July 2005 to July 2008 in the Cancer Hospital of Chinese Academy of Medical Sciences was presented.
  • The tumor originated in the anterior skull base in 19 cases, originated in the lateral skull base in 12, in the central skull base in 17, and in the posterior skull base in 6.
  • Total resection of tumor was achieved in 45 cases, and subtotal resection was achieved in 9.
  • All cases except 3 were followed up with a period of 8 to 43 months (median, 19.1 months for benign tumor and 21.0 months for malignant tumor).
  • Three patients with malignant tumor were lost.
  • Twelve cases of malignant tumor and one case of benign tumor recurred postoperatively.
  • Nine patients with malignant tumor had died (one of these died from heart trouble).
  • Three-year disease-free survival rates and overall survival rates of malignant tumor were 52.7% and 53.0%, respectively.
  • CONCLUSIONS: It suggested that a special operative team constituted of head and neck surgeon and neurosurgeon may improve the outcome of the difficult skull base tumors.
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Head / surgery. Humans. Male. Middle Aged. Neck / surgery. Survival Rate. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19954018.001).
  • [ISSN] 1673-0860
  • [Journal-full-title] Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • [ISO-abbreviation] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


33. Tatomirovic Z, Skuletic V, Bokun R, Trimcev J, Radic O, Cerovic S, Strbac M, Zolotarevski L, Tukic Lj, Stamatovic D, Tarabar O: Fine needle aspiration cytology in the diagnosis of head and neck masses: accuracy and diagnostic problems. J BUON; 2009 Oct-Dec;14(4):653-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine needle aspiration cytology in the diagnosis of head and neck masses: accuracy and diagnostic problems.
  • PURPOSE: Fine needle aspiration (FNA) cytology is an established technique associated with minimal complications compared with more invasive techniques such as wide core needle biopsy or open biopsy, and as such, very suitable for obtaining material in the delicate region of head and neck (H&N).
  • The overall accuracy rate of FNA cytology, whether malignant or benign, was 91.89%, while the diagnostic accuracy for the exact type of tumor was 87.16%.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Lymphoma / diagnosis. Pseudolymphoma / diagnosis
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / secondary. Biopsy, Fine-Needle. Biopsy, Needle. Carcinoma, Small Cell / diagnosis. Carcinoma, Small Cell / secondary. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / secondary. Cytological Techniques. Diagnosis, Differential. Diagnostic Errors. Humans. Neoplasm Staging. Prognosis. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Lymphoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20148458.001).
  • [ISSN] 1107-0625
  • [Journal-full-title] Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • [ISO-abbreviation] J BUON
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


34. Gong Y, Jalali M, Staerkel G: Fine needle aspiration cytology of a thyroid metastasis of metaplastic breast carcinoma: a case report. Acta Cytol; 2005 May-Jun;49(3):327-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Because of the heterogeneous nature of this tumor, cytologic interpretation on fine needle aspirates can be quite challenging.
  • This is especially true of metastatic lesions of this rare tumor type.
  • Clinical presentation and findings from a neck computed tomographic scan were strongly suggestive of a primary thyroid malignancy.
  • The aspirate specimen was composed of scant, highly atypical epithelial cells in a background of an abundant chondromyxoid matrix and scattered, benign follicular cells.

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15966298.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


35. Li HY, Xu W, Han DM, Hu R, Hu HY, Hou LZ, Zhang L, Ye JY, Wang J: [Self-assessment characteristics of voice handicap index for voice disorders and its influencing factors]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Feb;44(2):109-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • VHI scores were descending in order among spasmodic dysphonia, vocal fold paralysis, functional dysphonia, sulcus vocalis, benign and malignant tumor of vocal fold, vocal fold cyst, Reinke's edema, vocal fold polyp, vocal fold keratosis and chronic laryngitis, vocal nodule.
  • CONCLUSION: As a useful supplementary instrument to measure the voice disorder severity and the treatment's effect, VHI can comprehensively assess the voice handicap's affect to the life quality and the difference after the treatment, especially in physical, functional and emotional aspects, but it is somehow subject to the educational degree and age.

  • MedlinePlus Health Information. consumer health - Voice Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19558882.001).
  • [ISSN] 1673-0860
  • [Journal-full-title] Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • [ISO-abbreviation] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


36. Brochard C, Michalak S, Aubé C, Singeorzan C, Fournier HD, Laccourreye L, Calès P, Boursier J: A not so solitary fibrous tumor of the liver. Gastroenterol Clin Biol; 2010 Dec;34(12):716-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A not so solitary fibrous tumor of the liver.
  • Solitary fibrous tumor (SFT) is a rare neoplasm.
  • Liver parenchyma is a rare location of SFT and, in this case, it usually follows a benign course.
  • We report here the case of a 54-year-old man who presented a large SFT tumor of the right hepatic lobe.
  • The tumor was surgically resected.
  • Local recurrence occurred 6 years later as a 15 cm diameter liver tumor.
  • Two years later, the patient presented with complaints of neck pain and ensuing examinations revealed a tumor of the cranial base.
  • [MeSH-major] Liver Neoplasms / pathology. Skull Base Neoplasms / secondary. Solitary Fibrous Tumors / secondary

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 20864281.001).
  • [ISSN] 0399-8320
  • [Journal-full-title] Gastroentérologie clinique et biologique
  • [ISO-abbreviation] Gastroenterol. Clin. Biol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


37. Gehrking E, Gehrking I, Moubayed P: [Surgery of benign tumors of the parotid gland: the value of fine needle aspiration cytology]. HNO; 2007 Mar;55(3):195-201
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surgery of benign tumors of the parotid gland: the value of fine needle aspiration cytology].
  • In cases of benign tumors of the parotid gland, a (partial) superficial parotidectomy is usually recommended.
  • However, for tumors other than pleomorphic adenomas (such as cystadenolymphomas, other adenomas, or benign tumor-like lesions) this operation is considered an overtreatment because extracapsular satellites are rare and recurrences in case of a capsular lesion are not likely.
  • In such cases, a less extended surgery (enucleation) with lower morbidity is sufficient and can be carried out provided that pleomorphic adenomas and non-pleomorphic benign lesions are reliably differentiated prior to surgery.
  • The aim of this study was to evaluate the reliability of the FNAC in differentiating benign tumors of the parotid gland.
  • METHODS: A retrospective evaluation of 160 cases of benign parotid gland tumors was performed and the cytological diagnoses compared with the histomorphological results.
  • RESULTS: FNAC showed a sensitivity of 74.2% and a specificity of 89.8% for differentiation between pleomorphic adenomas and non-pleomorphic benign lesions.
  • The predictive value for pleomorphic adenomas was 82.1%, and for non-pleomorphic benign lesions 84.6%.
  • It is concluded that only an accurate diagnosis of non-pleomorphic adenoma or a benign tumor-like lesion, based on an adequate FNAC specimen and assessed by an experienced cytopathologist, can justify tumor enucleation because the risk of pleomorphic adenoma is only 2% under these circumstances.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] HNO. 2000 Jun;48(6):419-20 [10929221.001]
  • [Cites] Br J Surg. 1958 Mar 18;45(193):477-87 [13536351.001]
  • [Cites] Acta Cytol. 1991 May-Jun;35(3):357-9 [2042438.001]
  • [Cites] Arch Otolaryngol. 1979 May;105(5):247-51 [219819.001]
  • [Cites] J Craniomaxillofac Surg. 1987 Oct;15(5):278-80 [3479449.001]
  • [Cites] Br J Surg. 1986 Nov;73(11):897 [3024768.001]
  • [Cites] Laryngorhinootologie. 1998 May;77(5):283-8 [9644676.001]
  • [Cites] HNO. 1995 Oct;43(10):627-33 [7499170.001]
  • [Cites] Am J Surg. 1988 Oct;156(4):294-6 [3177754.001]
  • [Cites] J Laryngol Otol. 1990 Sep;104(9):706-8 [2172430.001]
  • [Cites] HNO. 1994 Jan;42(1):28-35 [8150670.001]
  • [Cites] Laryngoscope. 1994 Dec;104(12):1487-94 [7990639.001]
  • [Cites] Laryngoscope. 1994 Jul;104(7):799-803 [8022240.001]
  • [Cites] Laryngoscope. 1984 Mar;94(3):324-9 [6321863.001]
  • [Cites] Semin Diagn Pathol. 1986 Aug;3(3):219-26 [3039635.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1999 Oct;125(10):1166 [10522514.001]
  • [Cites] J Laryngol Otol. 1989 Feb;103(2):242 [2926279.001]
  • [Cites] J Laryngol Otol. 1988 Jul;102(7):603-5 [3411212.001]
  • [Cites] J Surg Oncol. 2000 Nov;75(3):208-9 [11088054.001]
  • [Cites] Rev Laryngol Otol Rhinol (Bord). 2004;125(2):75-80 [15462165.001]
  • [Cites] HNO. 1990 Nov;38(11):412-6 [2289899.001]
  • [Cites] Laryngoscope. 2000 Jun;110(6):924-7 [10852505.001]
  • [Cites] Oral Oncol. 2002 Jan;38(1):35-40 [11755819.001]
  • [Cites] Br J Surg. 1996 Dec;83(12):1747-9 [9038558.001]
  • [Cites] J R Coll Surg Edinb. 1992 Jun;37(3):155-8 [1328626.001]
  • [Cites] HNO. 2000 Jun;48(6):421-9 [10929222.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1992 Feb;101(2 Pt 1):185-8 [1739267.001]
  • [Cites] Acta Otolaryngol Suppl. 1998;537:75-81 [9870653.001]
  • [Cites] Acta Otolaryngol Suppl. 1993;500:113-6 [8452007.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1999 Oct;125(10):1166-7 [10522515.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1999 Oct;125(10):1164-5 [10522513.001]
  • [Cites] Otolaryngol Head Neck Surg. 1999 Sep;121(3):210-3 [10471859.001]
  • [Cites] Cancer. 2004 May 1;100(9):1876-83 [15112268.001]
  • (PMID = 17333048.001).
  • [ISSN] 1433-0458
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


38. Niu LJ, Hao YZ, Zhou CW: [Diagnostic value of ultrasonography in thyroid lesions]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jun;41(6):415-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The criterion of diagnosis for benign lesions were (1) multinodular;.
  • RESULTS: Of all cases, 1284 cases were benign and 416 cases malignant.
  • The accuracy rate of gray scale sonography for benign and malignant thyroid lesions was respectively 80. 0% and 75.0%.
  • The accuracy rate of ultrasound diagnosis for benign and malignant thyroid lesions was respectively 86.0% and 82.0%, total accuracy rate for thyroid lesion was 85.0%.
  • CONCLUSIONS: Gray scale sonography was very important to distinguishing between benign and malignant lesions of thyroid tumor, the accuracy rate was greatly improved with colour Doppler sonography, but the determination of blood flow index is no help to differentiating between benign and malignant lesions of thyroid tumor.

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16927795.001).
  • [ISSN] 1673-0860
  • [Journal-full-title] Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • [ISO-abbreviation] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


39. Mendes RA, Carvalho JF, van der Waal I: Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment - an overview. Oral Oncol; 2010 Jan;46(1):19-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biological pathways involved in the aggressive behavior of the keratocystic odontogenic tumor and possible implications for molecular oriented treatment - an overview.
  • In the classification of Head and Neck Tumors, published in 2005 by the World Health Organization Classification, the odontogenic keratocyst has been reclassified as a benign intraosseous neoplasm, calling it "keratocystic odontogenic tumor" (KCOT).
  • Genetic and molecular research regarding odontogenic tumors, and KCOTs in particular, has led to an increasing amount of knowledge and understanding of their physiopathological pathways.
  • A review of the biological behavior of this recognized aggressive pathological entity of the jaws and a contemporary outline of the molecular (growth factors, p53, PCNA and Ki-67, bcl-2) and genetic (PTCH, SHH) alterations associated with this odontogenic neoplasm provides a better understanding of the mechanisms involved in its development and strengthen the current concept that the KCOT should, indeed, be regarded as a neoplasm.
  • Furthermore, markers known to be rapidly induced in response to growth factors, tumor promoters, cytokines, bacterial endotoxins, oncogenes, hormones and shear stress, such as COX-2, may also shed new light on the biological mechanisms involved in the development of these benign but sometimes aggressive neoplasms of the jaws.
  • [MeSH-major] Jaw Neoplasms. Odontogenic Cysts. Odontogenic Tumors

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20004133.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  •  go-up   go-down


40. Zhang S, Bhalodia A, Swartz B, Abreo F, Fowler M: Fine needle aspiration of parapharyngeal space adult rhabdomyoma: a case report. Acta Cytol; 2010 Sep-Oct;54(5 Suppl):775-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Rhabdomyomas are rare benign tumors of striated muscle and include cardiac and extracardiac types.
  • The adult type is usually found in the head and neck regions of elderly persons.
  • Tumor cells were positive for desmin.

  • MedlinePlus Health Information. consumer health - Throat Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21053538.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


41. Spanu A, Solinas ME, Chessa F, Sanna D, Nuvoli S, Madeddu G: 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging. J Nucl Med; 2009 Feb;50(2):184-90
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We assigned an incremental value to SPECT/CT when it provided better identification and interpretation of the foci of radioiodine uptake, more correct anatomic localization and characterization, and precise differentiation between tumor lesions and physiologic uptake.
  • SPECT/CT was a determinant in classifying as neoplastic those foci for which planar imaging seemed to exclude malignancy, discriminating between residue and lymph node metastases in the neck, some of which were adjacent to salivary glands and had been missed on planar imaging.
  • Globally, SPECT/CT had an incremental value over planar imaging in 67.8% of patients, modified therapeutic management in 35.6% of positive cases, and avoided unnecessary treatment in 20.3% of patients with only single benign lesions or physiologic uptake.

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Nucl Med. 2009 Aug;50(8):1386; author reply 1386 [19617337.001]
  • (PMID = 19164225.001).
  • [ISSN] 0161-5505
  • [Journal-full-title] Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • [ISO-abbreviation] J. Nucl. Med.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Iodine Radioisotopes
  •  go-up   go-down


42. Gajda M, Welzel C, Holzhausen HJ, Jamali Y, Schrom T, Hauptmann S, Bloching M: [Multifocal adult rhabdomyoma of the neck: a rare entity]. Otolaryngol Pol; 2005;59(6):883-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Multifocal adult rhabdomyoma of the neck: a rare entity].
  • Extracardiac rhabdomyoma comprise 2% of all tumors of skeletal muscle differentiation.
  • Seventy percent of extracardiac rhabdomyoma occur in the head and neck region and have been subclassified into adult and fetal types.
  • A review of the world literature revealed about 19 acceptable cases of benign, multifocal adult-type rhabdomyoma with a distinct male predominance.
  • The pathogenesis of this benign striated muscle tumor is still unclear.
  • These slow-growing tumors remain asymptomatic for a long period.
  • The diagnosis of head and neck rhabdomyoma is based on histology and immunhistochemical studies.
  • The differential diagnoses of rhabdomyoma in adults are myoblastoma or Abrikossof tumor, reticulohistiocytoma, rhabdomyosarcoma and hibernoma.
  • Although adult rhabdomyomas have a distinct histology, they often are mistaken for a variety of other lesions, particularly Abrikossof tumor.
  • Electron microscopic studies confirmed the tumor's myogenic origin.
  • [MeSH-major] Head and Neck Neoplasms / pathology. Rhabdomyoma / pathology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16521457.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Number-of-references] 16
  •  go-up   go-down


43. Diaz RC, Amjad EH, Sargent EW, Larouere MJ, Shaia WT: Tumors and pseudotumors of the endolymphatic sac. Skull Base; 2007 Nov;17(6):379-93
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumors and pseudotumors of the endolymphatic sac.
  • Of these, three were true endolymphatic sac tumors and two were inflammatory pseudotumors of the endolymphatic sac.
  • All three of the endolymphatic sac tumors patients survived (100%), and two of the three had disease-free survival (67%).
  • Both patients with benign pseudotumors survived (100%).
  • Our study concluded that endolymphatic sac tumors are rare neoplasms of the temporal bone that, although locally aggressive and invasive, have excellent prognosis for survival with complete resection.
  • We report a new entity of pseudotumor of the endolymphatic sac that mimics true sac tumors in every respect on presentation but which is non-neoplastic in origin.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1997 Mar;202(3):801-8 [9051037.001]
  • [Cites] Laryngoscope. 1997 Feb;107(2):216-21 [9023246.001]
  • [Cites] J Natl Cancer Inst. 1997 Jul 2;89(13):970-2 [9214679.001]
  • [Cites] Neurosurgery. 1998 Apr;42(4):927-32 [9574660.001]
  • [Cites] Histopathology. 1998 Jul;33(1):2-10 [9726042.001]
  • [Cites] Top Magn Reson Imaging. 2000 Apr;11(2):108-22 [10794200.001]
  • [Cites] Cancer Res. 2000 Nov 1;60(21):5963-5 [11085513.001]
  • [Cites] Clin Imaging. 2001 May-Jun;25(3):154-62 [11679220.001]
  • [Cites] Otol Neurotol. 2002 May;23(3):378-87 [11981399.001]
  • [Cites] Acta Neurochir (Wien). 2002 Oct;144(10):1047-53 [12382133.001]
  • [Cites] N Engl J Med. 2004 Jun 10;350(24):2481-6 [15190140.001]
  • [Cites] Otol Neurotol. 2004 Jul;25(4):599-603 [15241241.001]
  • [Cites] Laryngoscope. 2004 Aug;114(8):1470-4 [15280728.001]
  • [Cites] Otol Neurotol. 2004 Sep;25(5):773-81 [15354010.001]
  • [Cites] J Clin Oncol. 2004 Dec 15;22(24):4991-5004 [15611513.001]
  • [Cites] Neurol Med Chir (Tokyo). 2004 Nov;44(11):595-9 [15686180.001]
  • [Cites] J Neurosurg. 2005 Mar;102(3):503-12 [15796386.001]
  • [Cites] J Neurosurg Spine. 2005 Jul;3(1):68-70 [16122027.001]
  • [Cites] Laryngoscope. 2006 Jan;116(1):40-6 [16481807.001]
  • [Cites] Lancet. 1991 May 4;337(8749):1052-4 [1673491.001]
  • [Cites] J Laryngol Otol. 1991 Nov;105(11):950-3 [1761952.001]
  • [Cites] Am J Otol. 1990 Jan;11(1):20-6 [2305851.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2292-302 [2804921.001]
  • [Cites] Surg Neurol. 1987 May;27(5):466-8 [3563861.001]
  • [Cites] Pract Otorhinolaryngol (Basel). 1969;31(2):65-83 [5790561.001]
  • [Cites] J Otolaryngol. 1984 Aug;13(4):213-6 [6471156.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1984 Nov-Dec;93(6 Pt 1):540-6 [6508125.001]
  • [Cites] Am J Otol. 1981 Oct;3(2):139-43 [7304722.001]
  • [Cites] Laryngoscope. 1980 Jun;90(6 Pt 2):1-39 [7412459.001]
  • [Cites] Laryngoscope. 1995 Aug;105(8 Pt 1):801-8 [7630290.001]
  • [Cites] Hum Mutat. 1995;5(1):66-75 [7728151.001]
  • [Cites] Radiology. 1993 Oct;189(1):199-204 [8372194.001]
  • [Cites] Otolaryngol Head Neck Surg. 1993 Feb;108(2):141-8 [8441538.001]
  • [Cites] Science. 1993 May 28;260(5112):1317-20 [8493574.001]
  • [Cites] Am J Otol. 1995 Nov;16(6):778-82 [8572141.001]
  • [Cites] Am J Otol. 1996 Jul;17(4):603-6 [8841706.001]
  • [Cites] JAMA. 1997 May 14;277(18):1461-6 [9145719.001]
  • (PMID = 18449331.001).
  • [ISSN] 1531-5010
  • [Journal-full-title] Skull base : official journal of North American Skull Base Society ... [et al.]
  • [ISO-abbreviation] Skull Base
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2111135
  • [Keywords] NOTNLM ; Endolymphatic sac tumor / hydrops / papillary adenoma / pseudotumor / von Hippel-Lindau disease
  •  go-up   go-down


44. El-Sayed IH, Huang X, El-Sayed MA: Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett; 2006 Jul 28;239(1):129-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two oral squamous carcinoma cell lines (HSC 313 and HOC 3 Clone 8) and one benign epithelial cell line (HaCaT) were incubated with anti-epithelial growth factor receptor (EGFR) antibody conjugated gold nanoparticles and then exposed to continuous visible argon ion laser at 514nm.
  • It is found that the malignant cells require less than half the laser energy to be killed than the benign cells after incubation with anti-EGFR antibody conjugated Au nanoparticles.
  • [MeSH-minor] Epithelial Cells / radiation effects. Humans. Immunoconjugates. Tumor Cells, Cultured

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GOLD, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16198049.001).
  • [ISSN] 0304-3835
  • [Journal-full-title] Cancer letters
  • [ISO-abbreviation] Cancer Lett.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Immunoconjugates; 7440-57-5 / Gold; EC 2.7.10.1 / Receptor, Epidermal Growth Factor
  •  go-up   go-down


45. Valdez TA, Desai U, Volk MS: Recurrent fetal rhabdomyoma of the head and neck. Int J Pediatr Otorhinolaryngol; 2006 Jun;70(6):1115-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent fetal rhabdomyoma of the head and neck.
  • A congenital fetal rhabdomyoma involving the head and neck region diagnosed prenatally by ultrasound and MRI was surgically excised without complications.
  • The patient presented with recurrence of the tumor fourteen months after the initial surgery.
  • Extracardiac rhabdomyomas are extremely rare benign tumors.
  • [MeSH-major] Head and Neck Neoplasms / congenital. Neoplasm Recurrence, Local / pathology. Rhabdomyoma / congenital

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16406074.001).
  • [ISSN] 0165-5876
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Ireland
  • [Number-of-references] 11
  •  go-up   go-down


46. Wu RC, Hsieh YY, Chang YC, Kuo TT: Cellular neurothekeoma with melanocytosis. J Cutan Pathol; 2008 Feb;35(2):241-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cellular neurothekeoma (CNT) is a benign dermal tumor mainly affecting the head and neck and the upper extremities.
  • The histogenesis of CNT has been controversial, although it is generally regarded as an immature counterpart of classic/myxoid neurothekeoma, a tumor with nerve sheath differentiation.
  • CNT harboring melanin-laden cells may pose diagnostic problems because of their close resemblance to nevomelanocytic lesions and other dermal mesenchymal tumors.

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18190453.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


47. Huang X, Sun W, Liu X, Liu W, Guan Z, Xu Y, Zheng Y: Endoscope-assisted partial-superficial parotidectomy through a concealed postauricular skin incision. Surg Endosc; 2009 Jul;23(7):1614-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Endoscope-assisted partial-superficial parotidectomy through a concealed postauricular skin incision was performed for 18 cases of benign tumor located in the superficial lobe of the parotid gland.
  • CONCLUSIONS: Endoscope-assisted partial-superficial parotidectomy is a feasible method for treatment of benign tumors located in the superficial lobe of the parotid gland.

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Thyroid. 2001 Feb;11(2):161-3 [11288985.001]
  • [Cites] Br J Surg. 1989 Oct;76(10):1034-5 [2597945.001]
  • [Cites] Laryngoscope. 2004 Feb;114(2):381-2 [14755223.001]
  • [Cites] Otolaryngol Head Neck Surg. 2003 Apr;128(4):530-3 [12707656.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1997 Oct;123(10):1081-7 [9339985.001]
  • [Cites] J Surg Oncol. 1998 Nov;69(3):178-80 [9846506.001]
  • [Cites] Acta Otolaryngol Suppl. 1993;504:137-9 [8385873.001]
  • [Cites] Head Neck. 2003 Nov;25(11):946-52 [14603455.001]
  • [Cites] Surgery. 1999 Dec;126(6):1117-21; discussion 1121-2 [10598196.001]
  • [Cites] Laryngoscope. 2002 Dec;112(12):2141-54 [12461331.001]
  • [Cites] Surg Endosc. 1997 Nov;11(11):1135 [9348395.001]
  • [Cites] Surg Endosc. 1997 Aug;11(8):877 [9266657.001]
  • [Cites] Ann Plast Surg. 2000 Sep;45(3):269-73 [10987528.001]
  • [Cites] Br J Surg. 1996 Jun;83(6):875 [8696772.001]
  • [Cites] Head Neck. 2006 Nov;28(11):1014-7 [16933310.001]
  • [Cites] Ear Nose Throat J. 2005 May;84(5):308, 310-1 [15971755.001]
  • [Cites] Laryngoscope. 2006 Jun;116(6):851-4 [16735906.001]
  • [Cites] Acta Otolaryngol. 2006 Dec;126(12):1321-5 [17101595.001]
  • [Cites] J Pathol. 1985 May;146(1):51-8 [4009321.001]
  • [Cites] J Am Coll Surg. 2000 Sep;191(3):336-40 [10989910.001]
  • [Cites] Am J Surg. 1990 Oct;160(4):377-81 [2171368.001]
  • [Cites] Surg Laparosc Endosc Percutan Tech. 2000 Feb;10(1):1-4 [10872517.001]
  • [Cites] Head Neck Surg. 1986 Jan-Feb;8(3):177-84 [3744850.001]
  • (PMID = 19343432.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


48. Ebbing J, Blind C, Stein H, Miller K, Loddenkemper C: Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy - urological viewpoint and overview of the literature to date. Rare Tumors; 2009;1(2):e54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy - urological viewpoint and overview of the literature to date.
  • Pleomorphic adenomas (benign mixed tumors) are the most common tumors of glandular origin in the head and neck and are one of the few benign neoplasms that can undergo malignant transformation.(1) Mixed tumors that are seemingly benign at the microscopic level but metastasize have been termed metastasizing mixed tumors (MZMTs).
  • The entity of metastasizing benign mixed tumors has been reported since the early 1940s, with up to approximately 50 cases described in the literature to date.
  • We report the case of a MZMT of the kidney almost 30 years after lateral parotidectomy owing to the same tumor entity.
  • For benign mixed tumors, we are unaware of more than two other cases of metastasis to the kidney that have been published, whereas metastases to the bone, lung, and lymph nodes are more common.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21139933.001).
  • [ISSN] 2036-3613
  • [Journal-full-title] Rare tumors
  • [ISO-abbreviation] Rare Tumors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2994456
  • [Keywords] NOTNLM ; carcinoma ex-mixed tumor / kidney metastasis / kidney tumor. / metastasizing mixed tumor / metastasizing pleomorphic adenoma
  •  go-up   go-down


49. Severo MD, Rosa VD, De Carli DM, Beck Mde O, Danbermam MF: [Neurofibroma of thyroid in a patient with neurofibromatosis type 1]. Arq Bras Endocrinol Metabol; 2008 Feb;52(1):131-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The neurofibromatosis type 1 (NF1), also known as von Recklinghausens disease, is an autosomal dominant disorder, with high degree of variability of clinical expression, usually involved with formation of tumors, with benign origin in the majority of cases mainly localized in the region of the head and neck and rarely incident in the thyroid area.
  • This case is relevant not only because of the rarity of the presentation of NF1, but also due to the likely association with MCT, an aggressive tumor that can be cured by surgery.


50. Speer AL, Schofield DE, Wang KS, Shin CE, Stein JE, Shaul DB, Mahour GH, Ford HR: Contemporary management of lipoblastoma. J Pediatr Surg; 2008 Jul;43(7):1295-300
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Lipoblastoma is a rare, benign, adipose tissue tumor.
  • The anatomical distribution was trunk (n = 12), extremity (n = 12), groin (n = 5), and neck (n = 3).
  • CONCLUSIONS: A staged approach with meticulous sparing of the neurovascular bundle provides excellent functional outcome for patients with large tumors.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18639685.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


51. Jonathan A, Rajshekhar V, Chacko G: Chondromyxoid fibroma of the seventh cervical vertebra. Neurol India; 2008 Jan-Mar;56(1):84-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chondromyxoid fibroma is a rare benign bone tumor representing less than 0.5% of all bone tumors.
  • A 35-year-old man presented with history of neck pain, restriction of neck movements, pain and numbness along the medial aspect of the left forearm and weakness with wasting of the left hand.
  • A presumptive diagnosis of a bony tumor such as an aneurysmal bone cyst or a giant cell tumor involving the seventh vertebral body was made on plain X-rays, MRI and bone scan.
  • On eight years' follow-up, CT scan showed no progression of the tumor with good alignment and fusion of the graft at the site of the corpectomy.

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18310848.001).
  • [ISSN] 0028-3886
  • [Journal-full-title] Neurology India
  • [ISO-abbreviation] Neurol India
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


52. Wang S, Jiang Y, Li C, Yang C, Lin X, Yang D, Chen E: [Resection of invasive head and neck neoplasms involving skull base]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Aug;21(15):703-5, 708
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Resection of invasive head and neck neoplasms involving skull base].
  • OBJECTIVE: To investigate the operative methods of invasive head and neck neoplasms involving skull base.
  • METHOD: Thirty-two cases with invasive head and neck neoplasms involving anterior and lateral skull base, from 1997 to 2005, were treated with surgical resection.
  • Nine surgical approaches including endoscopic transnasal approach for five cases, combined craniofacial approach for three cases, maxillary resection approach for 15 cases, transpalatal approach for one case, transmandibular approach for one case, lateral neck-mandibular incision approach for two cases, combined retroauricular and neck approach for one case, frontotemporal approach for two cases, and facial translocation approach for two cases were used to resect the tumors.
  • The tumors of the rest 27 cases were totally removed.
  • Eight cases with benign tumor were followed up for six months to eight years without recurrence and no one died.
  • For 24 cases with malignant tumor, survival rates of three and five years were 63.2% (12/19), 41.7% (5/12) respectively.
  • Favorable curative effect could be achieved by resecting tumors totally as possible, protecting important constitutions, and adopting proper reparative techniques.
  • [MeSH-major] Head and Neck Neoplasms / pathology. Head and Neck Neoplasms / surgery. Skull Base / pathology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17969525.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


53. Hunter CL, Pacione D, Hornyak M, Murali R: Giant-cell tumors of the cervical spine: case report. Neurosurgery; 2006 Nov;59(5):E1142-3; discussion E1143
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant-cell tumors of the cervical spine: case report.
  • OBJECTIVE: Giant-cell tumors of bone are rare, benign neoplasms that occur infrequently in the spine above the sacrum, and their presence in the cervical vertebrae is even more exceptional.
  • The authors report two cases of giant-cell tumors in the cervical vertebrae that were treated successfully with surgical excision and postoperative radiation as well as long-term follow-up.
  • CLINICAL PRESENTATION: Both patients presented with neck pain radiating into the upper extremities.
  • INTERVENTION: In one case, the tumor was treated by anterior resection, then by laminectomy and instrumented fusion, and finally by adjuvant postoperative radiotherapy.
  • However, the tumor recurred, and, after several surgical procedures, external beam radiotherapy was administered.
  • The patients have been followed for 17 and 11 years, respectively, with no evidence of tumor recurrence.
  • CONCLUSION: Radical resection of giant-cell tumors is generally agreed to be the best treatment option.
  • However, complete resection is often not a feasible option for tumors in the cervical spine because of involvement of critical neurovascular structures.
  • [MeSH-major] Cervical Vertebrae / surgery. Giant Cell Tumor of Bone / diagnosis. Giant Cell Tumor of Bone / surgery. Laminectomy / methods. Spinal Neoplasms / diagnosis. Spinal Neoplasms / surgery. Thoracic Vertebrae / surgery

  • MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17143206.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


54. Rongioletti F, De Lucchi S, Meyes D, Mora M, Rebora A, Zupo S, Cerruti G, Patterson JW: Follicular mucinosis: a clinicopathologic, histochemical, immunohistochemical and molecular study comparing the primary benign form and the mycosis fungoides-associated follicular mucinosis. J Cutan Pathol; 2010 Jan;37(1):15-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Follicular mucinosis: a clinicopathologic, histochemical, immunohistochemical and molecular study comparing the primary benign form and the mycosis fungoides-associated follicular mucinosis.
  • RESULTS: Patients with PFM were more frequently younger (mean age 39 years), women (F:M=3:1), and presented with a solitary lesion involving the head/neck area more often than patients with LAFM who were older (mean age 54 years), men (M:F=2:1), and presented with multiple lesions on areas of the body other than the head/neck area.
  • [MeSH-minor] Adolescent. Adult. Biomarkers, Tumor / metabolism. Child. Diagnosis, Differential. Female. Gene Rearrangement. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Male. Middle Aged. Mucins / metabolism. Young Adult


55. Henrique R, Jerónimo C, Hoque MO, Carvalho AL, Oliveira J, Teixeira MR, Lopes C, Sidransky D: Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions. DNA Cell Biol; 2005 Apr;24(4):264-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
  • 14-3-3Sigma is a putative tumor suppressor gene involved in cell cycle regulation and apoptosis following DNA damage.
  • Here, we investigate the frequency and extent of 14-3-3sigma promoter methylation in benign and cancerous prostate tissues.
  • We examined tumor tissue from 121 patients with prostate carcinoma (PCa), 39 paired high-grade prostatic intraepithelial neoplasias (HGPIN), 29 patients with benign prostate hyperplasia (BPH), as well as four prostate cancer cell lines using quantitative methylation-specific PCR (QMSP).
  • [MeSH-major] Adenocarcinoma / genetics. Biomarkers, Tumor / metabolism. DNA Methylation. Exonucleases / metabolism. Gene Silencing. Neoplasm Proteins / metabolism. Prostatic Hyperplasia / genetics. Prostatic Intraepithelial Neoplasia / genetics. Prostatic Neoplasms / genetics
  • [MeSH-minor] 14-3-3 Proteins. Analysis of Variance. Cell Line, Tumor. Exoribonucleases. Histological Techniques. Humans. Male. Polymerase Chain Reaction / methods. Portugal. Promoter Regions, Genetic / genetics. Prostate / pathology. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Enlarged Prostate (BPH).
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15812243.001).
  • [ISSN] 1044-5498
  • [Journal-full-title] DNA and cell biology
  • [ISO-abbreviation] DNA Cell Biol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 14-3-3 Proteins; 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins; EC 3.1.- / Exonucleases; EC 3.1.- / Exoribonucleases; EC 3.1.- / SFN protein, human
  •  go-up   go-down


56. Mäkitie AA, Törnwall J, Mäkitie O: Bisphosphonate treatment in craniofacial fibrous dysplasia--a case report and review of the literature. Clin Rheumatol; 2008 Jun;27(6):809-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fibrous dysplasia (FD) is a benign skeletal disorder which may affect one or multiple bones.
  • She presented with a tumor-like lesion of the mandible.

  • Genetic Alliance. consumer health - Fibrous Dysplasia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Minerva Stomatol. 2002 Jul-Aug;51(7-8):293-300 [12434124.001]
  • [Cites] Laryngorhinootologie. 2007 Mar;86(3):184-92 [17131258.001]
  • [Cites] J Craniomaxillofac Surg. 2004 Feb;32(1):10-5 [14729043.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Jun;91(6):2017-20 [16551739.001]
  • [Cites] Head Neck Surg. 1987 Mar-Apr;9(4):202-10 [3667297.001]
  • [Cites] J Bone Miner Res. 2006 Dec;21 Suppl 2:P99-P104 [17229019.001]
  • [Cites] J Oral Maxillofac Surg. 2001 Feb;59(2):157-67; discussion 167-8 [11213984.001]
  • [Cites] J Bone Miner Res. 2006 Dec;21 Suppl 2:P110-3 [17228998.001]
  • [Cites] Curr Opin Oncol. 2007 Jul;19(4):315-22 [17545793.001]
  • [Cites] Orbit. 2000 Jun;19(2):119-128 [12045956.001]
  • [Cites] Plast Reconstr Surg. 2007 Dec;120(7):1957-62 [18090759.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2001 Oct;127(10 ):1239-47 [11587606.001]
  • [Cites] Head Neck. 1992 Nov-Dec;14 (6):510-2 [1468928.001]
  • [Cites] J Bone Miner Res. 2006 Dec;21 Suppl 2:P114-9 [17228999.001]
  • [Cites] J Craniofac Surg. 2002 May;13(3):382-9 [12040205.001]
  • (PMID = 18247080.001).
  • [ISSN] 0770-3198
  • [Journal-full-title] Clinical rheumatology
  • [ISO-abbreviation] Clin. Rheumatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Bone Density Conservation Agents; 0 / Diphosphonates
  • [Number-of-references] 15
  •  go-up   go-down


57. Wang Q, Wang S, Zhou S, Lu Y: [Clinical analysis of the primary nasal septum mass in 253 cases]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan;23(2):60-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSION: If the diagnosis was confirmed, the effect of the surgical treatment for the nasal septum benign tumor is satisfactory.
  • Follow-up should be done in cases with malignant tendency and malignant tumors.

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19452708.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


58. Gupta SC, Sachin J, Savyasachi S, Ritesh J, Neha G, Singh HP: Solitary nasal schwannoma clinically presenting as an angiofibroma of the nasopharynx. Ear Nose Throat J; 2010 Jul;89(7):E28-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Benign schwannomas of the nasal cavity are rare.
  • The tumor was removed via a transpalatal approach.

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20628976.001).
  • [ISSN] 1942-7522
  • [Journal-full-title] Ear, nose, & throat journal
  • [ISO-abbreviation] Ear Nose Throat J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


59. Al-Momani HM: Recurrent maturing perineal lipoblastoma. Saudi Med J; 2005 Nov;26(11):1815-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lipoblastoma is a rare benign neoplasm of fetal adipose tissue that we see mostly in infants and young children less than 3 years of age.
  • Most lipoblastomas occur on the extremities, trunk, head and neck, and various other organs have been described.
  • We report a case of a recurrent perineal lipoblastoma in a 2.5-year-old boy, which showed maturation of the lipoblasts as compared to the primary tumor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16311674.001).
  • [ISSN] 0379-5284
  • [Journal-full-title] Saudi medical journal
  • [ISO-abbreviation] Saudi Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Saudi Arabia
  •  go-up   go-down


60. Gil Z, Constantini S, Spektor S, Abergel A, Khafif A, Beni-Adani L, Leonor TL, DeRowe A, Fliss DM: Skull base approaches in the pediatric population. Head Neck; 2005 Aug;27(8):682-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: This study aimed to examine the surgical, oncologic, and developmental results of infants and children undergoing extirpation of skull base tumors.
  • Eighteen cases (27%) involved malignant tumors, and 49 (73%) involved benign tumors.
  • The most common benign tumors were craniopharyngioma (n = 10) and juvenile nasopharyngeal angiofibroma (n = 8).
  • The most common malignant tumor was sarcoma (n = 5).
  • Thirty-six tumors (55%) involved the anterior skull base, and the rest involved the lateral (n = 24) and posterior (n = 7) skull base.
  • Subcranial, transfacial, and subfrontal approaches were used for extirpation of anterior skull base tumors.
  • Voluminous or malignant tumors were excised by use of combined approaches (subcranial-transfacial, subcranial-degloving, or pterional-degloving).
  • CONCLUSION: The extirpation of skull base tumors by use of conventional surgical techniques is feasible and safe among infants and children.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley Periodicals, Inc.
  • (PMID = 15957193.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


61. Fliss DM, Abergel A, Cavel O, Margalit N, Gil Z: Combined subcranial approaches for excision of complex anterior skull base tumors. Arch Otolaryngol Head Neck Surg; 2007 Sep;133(9):888-96
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined subcranial approaches for excision of complex anterior skull base tumors.
  • OBJECTIVE: To present our method for excision of complex anterior skull base tumors via combinations of the subcranial approach.
  • PATIENTS: Of 120 anterior skull base tumor resections, 41 that included 27 (66%) malignant and 14 (34%) benign lesions were performed via combinations of the subcranial approach.
  • Unilateral or bilateral medial maxillectomy was performed using the subcranial approach alone for 13 tumors infiltrating the anterior skull base, ethmoid bones, and medial maxillary wall.
  • A combined subcranial-transfacial approach in 2 lesions or a combined subcranial-midfacial degloving approach in 14 lesions was performed for tumors involving the skull base and the lower or lateral segments of the maxilla.
  • A combined subcranial-transorbital or transfacial-transorbital approach was used for 5 tumors invading the orbit.
  • An extended subcranial-orbitozygomatic approach was used for 6 tumors invading the middle cranial fossa or involving the cavernous sinus.
  • RESULTS: Thirty-seven of 41 tumors (90%) were completely resected.
  • Two-year overall and disease-free survival in patients with malignant tumors who underwent combined approaches was 66% and 60%, respectively.
  • CONCLUSION: Combinations and modifications of the subcranial approach for excision of complex anterior skull base tumors yield surgical results, survival, quality of life, and complications similar to those found with the classic subcranial technique.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17875855.001).
  • [ISSN] 0886-4470
  • [Journal-full-title] Archives of otolaryngology--head & neck surgery
  • [ISO-abbreviation] Arch. Otolaryngol. Head Neck Surg.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


62. Tse GM, Wong FC, Tsang AK, Lee CS, Lui PC, Lo AW, Law BK, Scolyer RA, Karim RZ, Putti TC: Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour. J Clin Pathol; 2005 Jun;58(6):600-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
  • BACKGROUND: Nitric oxide synthase (NOS), particularly endothelial and inducible forms (e/i-NOS), are expressed in various cancers, including breast cancer.
  • In mammary fibroepithelial lesions, NOS expression in stromal cells has been reported to be lower in fibroadenomas than in phyllodes tumours.
  • AIMS: To investigate NOS expression in phyllodes tumours of varying degrees of malignancy.
  • METHODS: One hundred and sixty seven mammary phyllodes tumours (97 benign, 47 borderline malignant, and 23 frankly malignant) were evaluated for e-NOS and i-NOS expression by immunohistochemistry.
  • RESULTS: Stromal expression of e-NOS was absent, weak, moderate, and strong in 43%, 31%, 13%, and 13% of benign tumours; 17%, 26%, 13%, and 44% of borderline malignant tumours; and 17%, 35%, 13%, and 35% of frankly malignant tumours, respectively.
  • Stromal expression of i-NOS was 77%, 18%, 4%, and 1% in benign tumours; 42%, 28%, 19%, and 11% in borderline malignant tumours; and 43%, 13%, 26%, and 18% in frankly malignant tumours, respectively.
  • Stromal expression of both i-NOS and e-NOS was significantly different between the benign and malignant (borderline and frank) groups of phyllodes tumours (p < 0.0001).
  • Furthermore, the expression of i-NOS correlated with stromal VEGF expression and microvessel density.
  • The expression of NOS in the epithelial cells was strong, and showed no differences between the different groups of tumours.
  • CONCLUSIONS: Higher stromal expression of NOS in phyllodes tumours is associated with malignancy, suggesting a possible role in malignant progression, particularly metastasising potential.
  • [MeSH-major] Breast Neoplasms / enzymology. Nitric Oxide Synthase / metabolism. Phyllodes Tumor / enzymology

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lab Invest. 1999 Oct;79(10):1215-25 [10532585.001]
  • [Cites] Cancer Lett. 1999 Sep 20;144(1):65-74 [10503879.001]
  • [Cites] Tumour Biol. 2000 Mar-Apr;21(2):90-7 [10686538.001]
  • [Cites] Clin Cancer Res. 2000 Jun;6(6):2408-16 [10873093.001]
  • [Cites] Int J Oncol. 2000 Oct;17(4):667-71 [10995876.001]
  • [Cites] Histochem Cell Biol. 2002 Jan;117(1):13-9 [11819093.001]
  • [Cites] Mod Pathol. 2002 Jul;15(7):734-40 [12118111.001]
  • [Cites] Cancer. 2002 Sep 15;95(6):1191-8 [12216084.001]
  • [Cites] Eur J Surg Oncol. 2003 Sep;29(7):619-23 [12943630.001]
  • [Cites] Mod Pathol. 2003 Oct;16(10):1007-13 [14559983.001]
  • [Cites] Hum Pathol. 2004 Sep;35(9):1053-7 [15343505.001]
  • [Cites] Radiology. 1983 Feb;146(2):481-6 [6294737.001]
  • [Cites] J Exp Med. 1989 May 1;169(5):1543-55 [2497225.001]
  • [Cites] Surg Gynecol Obstet. 1990 Mar;170(3):193-6 [2154867.001]
  • [Cites] J Surg Oncol. 1990 Sep;45(1):46-51 [2166186.001]
  • [Cites] Br J Pharmacol. 1992 Dec;107(4):1092-5 [1281718.001]
  • [Cites] Am J Surg. 1993 Mar;165(3):376-9 [8383473.001]
  • [Cites] J Immunol. 1993 Apr 15;150(8 Pt 1):3478-86 [8385686.001]
  • [Cites] Cancer Res. 1994 Mar 1;54(5):1352-4 [7509718.001]
  • [Cites] Biochem J. 1994 Mar 1;298 ( Pt 2):249-58 [7510950.001]
  • [Cites] Cancer Res. 1994 May 1;54(9):2462-7 [8162595.001]
  • [Cites] Lancet. 1994 May 14;343(8907):1199-206 [7909873.001]
  • [Cites] Cancer Res. 1995 Feb 15;55(4):727-30 [7531613.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 May 9;92(10):4392-6 [7538668.001]
  • [Cites] Br J Cancer. 1995 Jul;72(1):41-4 [7541238.001]
  • [Cites] Otolaryngol Head Neck Surg. 1995 Nov;113(5):541-9 [7478643.001]
  • [Cites] Biochem Biophys Res Commun. 1996 Jul 5;224(1):153-8 [8694803.001]
  • [Cites] Br J Cancer. 1996 Nov;74(9):1423-6 [8912539.001]
  • [Cites] Mod Pathol. 1997 Jul;10(7):645-9 [9237172.001]
  • [Cites] Cancer Res. 1997 Aug 15;57(16):3365-9 [9269997.001]
  • [Cites] Carcinogenesis. 1997 Sep;18(9):1841-5 [9328184.001]
  • [Cites] Free Radic Biol Med. 1998 Jan 15;24(2):341-8 [9433910.001]
  • [Cites] Cancer Res. 1998 Jan 15;58(2):334-41 [9443414.001]
  • [Cites] Cancer. 1998 May 15;82(10):1897-903 [9587122.001]
  • [Cites] Cancer Res. 1998 Jul 15;58(14):2929-34 [9679948.001]
  • [Cites] Br J Cancer. 1998 Jul;78(2):233-9 [9683299.001]
  • [Cites] Lab Invest. 1998 Aug;78(8):949-55 [9714182.001]
  • [Cites] Jpn J Cancer Res. 1998 Jul;89(7):696-702 [9738975.001]
  • [Cites] J Urol. 1999 Feb;161(2):630-4 [9915473.001]
  • [Cites] Clin Cancer Res. 1999 May;5(5):1093-7 [10353743.001]
  • [Cites] Breast Cancer Res Treat. 1999 Jul;56(2):145-51 [10573107.001]
  • (PMID = 15917410.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Vascular Endothelial Growth Factor A; EC 1.14.13.39 / NOS2 protein, human; EC 1.14.13.39 / NOS3 protein, human; EC 1.14.13.39 / Nitric Oxide Synthase; EC 1.14.13.39 / Nitric Oxide Synthase Type II; EC 1.14.13.39 / Nitric Oxide Synthase Type III
  • [Other-IDs] NLM/ PMC1770683
  •  go-up   go-down


63. Zhou L, Chen X, Huang W, Li K, Zhang X, Wang W: [Surgical management of minor salivary gland tumors]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Nov;21(21):963-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surgical management of minor salivary gland tumors].
  • OBJECTIVE: To study the clinical features of minor salivary gland tumors and to discuss the treatment modalities for these tumors.
  • METHOD: Retrospective analysis of 54 cases with minor salivary gland tumor operated in our hospital from 1997 to 2004.
  • RESULT: Among 54 cases with minor salivary gland tumors in this series, 16 patients lost of follow up.
  • Among the remaining 38 patients, 2 patients with nasal cavity adenoid cystic carcinoma died of tumor recurrence 2 and 3 years after the surgery respectively, one patient with laryngeal myoepithelial carcinoma died of tumor recurrence 3 years after the surgery and one patient with paranasal sinus mucoepidermoid carcinoma died of recurrence 17 months after the surgery.
  • Two patients with paranasal sinus adenoid cystic carcinoma recurred after the primary surgery and were survived without tumor after salvage surgery.
  • The other patients survived with no tumor recurrence.
  • CONCLUSION: While different histopathology of minor salivary gland tumors were found in this group, malignant tumors were predominant, accounting for 81.4%.
  • The choice of treatment for minor salivary gland tumors depends upon the location and the histopathology of the tumors.
  • The treatment policy for benign tumors is simple tumor excision, while that for malignant tumors is surgery combined with pre- or post-operative radiation therapy.
  • Complete surgical resection of tumor masses and tumor free margin is essential for successful treatment of malignant minor salivary gland tumors.

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18309648.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


64. Wilkins-Port CE, Ye Q, Mazurkiewicz JE, Higgins PJ: TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1. Cancer Res; 2009 May 1;69(9):4081-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The phenotypic switching called epithelial-to-mesenchymal transition is frequently associated with epithelial tumor cell progression from a comparatively benign to an aggressive, invasive malignancy.
  • TGF-beta in the tumor microenvironment promotes invasive traits largely through reprogramming gene expression, which paradoxically supports matrix-disruptive as well as stabilizing processes. ras-transformed HaCaT II-4 keratinocytes undergo phenotypic changes typical of epithelial-to-mesenchymal transition, acquire a collagenolytic phenotype, and effectively invade collagen type 1 gels as a consequence of TGF-beta1 + EGF stimulation in a three-dimensional physiologically relevant model system that monitors collagen remodeling.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Sci. 2000 Jan;113 Pt 2:227-35 [10633074.001]
  • [Cites] J Surg Res. 2008 May 1;146(1):32-42 [17543340.001]
  • [Cites] J Interferon Cytokine Res. 2001 Jan;21(1):11-9 [11177576.001]
  • [Cites] Jpn J Cancer Res. 2001 Mar;92(3):257-68 [11267935.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6686-91 [11390996.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):813-20 [11448356.001]
  • [Cites] Nat Genet. 2001 Oct;29(2):117-29 [11586292.001]
  • [Cites] Biochemistry (Mosc). 2002 Jan;67(1):92-8 [11841344.001]
  • [Cites] Nat Rev Cancer. 2002 Jun;2(6):442-54 [12189386.001]
  • [Cites] Cancer Detect Prev. 2002;26(3):222-8 [12269770.001]
  • [Cites] J Biol Chem. 2002 Nov 22;277(47):45154-61 [12192005.001]
  • [Cites] Lab Invest. 2003 Mar;83(3):435-48 [12649344.001]
  • [Cites] Mol Cell Biochem. 2003 Nov;253(1-2):269-85 [14619979.001]
  • [Cites] Curr Opin Cell Biol. 2003 Dec;15(6):740-6 [14644200.001]
  • [Cites] J Biol Chem. 2004 May 21;279(21):22595-604 [15001579.001]
  • [Cites] Exp Eye Res. 2004 Aug;79(2):263-74 [15325573.001]
  • [Cites] Oncogene. 2008 Apr 17;27(18):2626-34 [17982486.001]
  • [Cites] Clin Exp Metastasis. 2008;25(6):593-600 [18286378.001]
  • [Cites] Oncogene. 2008 Aug 14;27(35):4841-53 [18427549.001]
  • [Cites] Ann Oncol. 2008 Sep;19(9):1566-72 [18503039.001]
  • [Cites] J Immunol. 2004 Sep 15;173(6):3605-11 [15356104.001]
  • [Cites] Curr Opin Cell Biol. 2004 Oct;16(5):558-64 [15363807.001]
  • [Cites] Ann N Y Acad Sci. 1990;580:225-32 [2186691.001]
  • [Cites] Exp Cell Res. 1991 Mar;193(1):93-100 [1995305.001]
  • [Cites] Matrix Suppl. 1992;1:368-74 [1480062.001]
  • [Cites] J Biol Chem. 1993 Aug 15;268(23):17341-7 [8349617.001]
  • [Cites] Cancer Res. 1994 Sep 1;54(17):4671-5 [8062262.001]
  • [Cites] Mol Carcinog. 1994 Sep;11(1):19-28 [7916986.001]
  • [Cites] EMBO J. 1995 Jul 3;14(13):2969-77 [7621813.001]
  • [Cites] Cell. 1996 Aug 23;86(4):531-42 [8752208.001]
  • [Cites] Biochem J. 1996 Dec 1;320 ( Pt 2):659-64 [8973581.001]
  • [Cites] Cell Growth Differ. 1997 Feb;8(2):243-50 [9040946.001]
  • [Cites] Br J Cancer. 1998 Mar;77(5):724-30 [9514050.001]
  • [Cites] Nat Med. 1998 Aug;4(8):923-8 [9701244.001]
  • [Cites] Mol Carcinog. 1998 Nov;23(3):144-58 [9833775.001]
  • [Cites] Biochem J. 1999 Apr 1;339 ( Pt 1):167-75 [10085241.001]
  • [Cites] Mol Biol Cell. 2004 Dec;15(12):5242-54 [15371548.001]
  • [Cites] Neoplasia. 2005 Jan;7(1):57-66 [15720817.001]
  • [Cites] Br J Cancer. 2005 Jun 20;92(12):2171-80 [15928670.001]
  • [Cites] J Dtsch Dermatol Ges. 2005 Jul;3(7):493-503 [15967008.001]
  • [Cites] J Clin Invest. 2005 Jul;115(7):1714-23 [15937546.001]
  • [Cites] J Cell Biochem. 2005 Aug 1;95(5):918-31 [15861394.001]
  • [Cites] Exp Cell Res. 2006 Apr 15;312(7):1093-105 [16457817.001]
  • [Cites] Front Biosci. 2006;11:3100-20 [16720379.001]
  • [Cites] Arthritis Rheum. 2006 Oct;54(10):3244-53 [17009259.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2107-14 [17119035.001]
  • [Cites] Exp Cell Res. 2007 Jul 1;313(11):2367-77 [17467690.001]
  • [Cites] Eur Urol. 2007 Sep;52(3):791-7 [17207914.001]
  • [Cites] Oncogene. 2008 Jan 24;27(5):614-28 [17637750.001]
  • [Cites] Biochem Pharmacol. 2000 Oct 15;60(8):1091-9 [11007946.001]
  • (PMID = 19383899.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / T32-HL07194; United States / NIGMS NIH HHS / GM / GM57242; United States / NIGMS NIH HHS / GM / GM057242-11; United States / NHLBI NIH HHS / HL / T32 HL007194; United States / NIGMS NIH HHS / GM / R01 GM057242; United States / NIGMS NIH HHS / GM / R01 GM057242-11
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Collagen Type I; 0 / Plasminogen Activator Inhibitor 1; 0 / SERPINE1 protein, human; 0 / Transforming Growth Factor beta1; 62229-50-9 / Epidermal Growth Factor; EC 3.4.21.7 / Fibrinolysin; EC 3.4.24.22 / Matrix Metalloproteinase 10; EC 3.4.24.7 / Matrix Metalloproteinase 1
  • [Other-IDs] NLM/ NIHMS242077; NLM/ PMC2962982
  •  go-up   go-down


65. Jaswal A, Jana AK, Biswas M, Sikder B, Nandi TK: Recurrent odontogenic myxoma of maxilla: a diagnostic and operative dilemma. Indian J Otolaryngol Head Neck Surg; 2008 Mar;60(1):41-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is a slow growing benign, locally malignant tumor notorious for recurrence.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Oral Maxillofac Surg. 1994 Oct;32(5):298-302 [7999737.001]
  • [Cites] Head Neck. 1996 Sep-Oct;18(5):459-64 [8864738.001]
  • [Cites] Eur J Radiol. 2001 Jan;37(1):1-4 [11274831.001]
  • (PMID = 23120497.001).
  • [ISSN] 2231-3796
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3450724
  • [Keywords] NOTNLM ; Maxilla / Odontogenic myxoma / Recurrent
  •  go-up   go-down


66. Do NY, Cho SI, Park JH, Choi JY: Lipoblastoma arising from the submandibular region. J Pediatr Surg; 2008 Nov;43(11):e13-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A lipoblastoma is a rare, benign tumor arising from embryonic white fat.
  • The tumors occur primarily in infancy and early childhood and commonly arise from the limbs and the trunk, but neck involvement is extremely rare.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Lipoma / diagnosis

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18970913.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


67. Kuratomi Y, Satoh S, Hayashida S, Inokuchi A: Basal cell adenoma and lymphoepithelial cyst as recurrent tumors of pleomorphic adenoma of the parotid gland. Auris Nasus Larynx; 2006 Mar;33(1):97-100
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Basal cell adenoma and lymphoepithelial cyst as recurrent tumors of pleomorphic adenoma of the parotid gland.
  • Basal cell adenoma of the parotid gland is a rare benign tumor.
  • Lymphoepithelial cyst of the parotid gland is also a rare benign tumor-like lesion.
  • These rare tumors should be considered in the differential diagnosis of recurrent masses after a removal of pleomorphic adenoma of the parotid gland.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16171964.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


68. Tonni G, De Felice C, Centini G, Ginanneschi C: Cervical and oral teratoma in the fetus: a systematic review of etiology, pathology, diagnosis, treatment and prognosis. Arch Gynecol Obstet; 2010 Oct;282(4):355-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • (1) teratomas are rare, usually benign congenital tumors which recognized multifactorial etiology;.
  • (5) delivery should involve elective Cesarean section with ex utero intrapartum treatment procedure or resection of the tumor mass, which may be performed on placental support operation on placental support procedure to increase the chances of postnatal survival.
  • [MeSH-major] Fetus / surgery. Head and Neck Neoplasms. Mouth Neoplasms. Teratoma

  • Genetic Alliance. consumer health - Teratoma.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20473617.001).
  • [ISSN] 1432-0711
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  •  go-up   go-down


69. Martino F, Avila LF, Encinas JL, Luis AL, Olivares P, Lassaletta L, Nistal M, Tovar JA: Teratomas of the neck and mediastinum in children. Pediatr Surg Int; 2006 Aug;22(8):627-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Teratomas of the neck and mediastinum in children.
  • This retrospective study reviews a series of teratomas of the neck and mediastinum aiming at defining the features of these particular locations.
  • Surgical treatment involved total tumor removal and in one case subsequent removal of lymph node metastases.
  • Teratomas of the neck may cause fetal disease and unmanageable neonatal airway obstruction.
  • In contrast, only some mediastinal tumors cause respiratory embarrassment.
  • Although benign, these tumors are sometimes immature and may metastasize to regional lymph nodes.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Head and Neck Neoplasms / surgery. Mediastinal Neoplasms / diagnosis. Mediastinal Neoplasms / surgery. Teratoma / diagnosis. Teratoma / surgery

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Perinat Med. 2004;32(6):500-8 [15576271.001]
  • [Cites] J Pediatr Surg. 2003 Mar;38(3):446-50; discussion 446-50 [12632365.001]
  • [Cites] Eur J Pediatr Surg. 2000 Aug;10(4):252-7 [11034516.001]
  • [Cites] J Pediatr Surg. 2004 Jul;39(7):1003-13 [15213888.001]
  • [Cites] J Thorac Cardiovasc Surg. 1983 Nov;86(5):727-31 [6632945.001]
  • [Cites] Am J Perinatol. 1998 Apr;15(4):253-7 [9565224.001]
  • [Cites] J Pediatr Surg. 2003 Apr;38(4):E12 [12677599.001]
  • [Cites] J Pediatr Surg. 1986 Jun;21(6):548-51 [2425069.001]
  • [Cites] J Pediatr Surg. 1995 Feb;30(2):312-6 [7537809.001]
  • [Cites] Pediatr Surg Int. 1998 Dec;14(3):212-3 [9880752.001]
  • [Cites] Acta Obstet Gynecol Scand. 1982;61(1):7-12 [7046336.001]
  • [Cites] Histopathology. 1988 May;12(5):491-502 [3397045.001]
  • [Cites] Am Surg. 1997 May;63(5):459-61 [9128238.001]
  • [Cites] Eur Radiol. 2003 Jul;13(7):1538-48 [12695920.001]
  • [Cites] J Pediatr Surg. 1983 Aug;18(4):382-6 [6620078.001]
  • [Cites] Semin Diagn Pathol. 1999 Feb;16(1):42-50 [10355653.001]
  • [Cites] Z Kinderchir. 1982 Jan;35(1):9-11 [7064584.001]
  • [Cites] J Pediatr Surg. 1989 Jan;24(1):21-3 [2723988.001]
  • [Cites] Fetal Diagn Ther. 2005 May-Jun;20(3):214-8 [15824501.001]
  • [Cites] J Pediatr Surg. 1998 Apr;33(4):553-8 [9574750.001]
  • [Cites] J Otolaryngol. 1997 Aug;26(4):246-52 [9263894.001]
  • [Cites] AJR Am J Roentgenol. 1997 Oct;169(4):985-90 [9308448.001]
  • [Cites] J Pediatr Surg. 2001 Jan;36(1):18-24 [11150432.001]
  • [Cites] J Pediatr Surg. 1988 Jun;23(6):583-91 [3047360.001]
  • [Cites] J Pediatr Surg. 1993 Sep;28(9):1161-4 [7508501.001]
  • [Cites] Pediatr Surg Int. 2000;16(5-6):333-7 [10955557.001]
  • [Cites] Ultrasound Obstet Gynecol. 2001 Nov;18(5):543-6 [11844182.001]
  • [Cites] J Pediatr Surg. 2003 Dec;38(12):1846 [14666486.001]
  • [Cites] J Pediatr Surg. 1999 Nov;34(11):1633-7 [10591558.001]
  • [Cites] J Clin Ultrasound. 1984 Oct;12(8):509-11 [6436332.001]
  • [Cites] Pediatr Radiol. 1998 Sep;28(9):709-10 [9732501.001]
  • [Cites] AJNR Am J Neuroradiol. 2004 Aug;25(7):1251-5 [15313719.001]
  • [Cites] Prenat Diagn. 1993 Dec;13(12 ):1079-84 [8177827.001]
  • [Cites] Plast Reconstr Surg. 1986 Mar;77(3):469-73 [3513222.001]
  • [Cites] AJR Am J Roentgenol. 1982 Dec;139(6):1220-2 [6983274.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2004 Sep;68(9):1133-9 [15302143.001]
  • [Cites] Radiographics. 1999 Oct;19 Spec No:S229-41 [10517457.001]
  • [Cites] Prenat Diagn. 1994 Sep;14 (9):884-7 [7845899.001]
  • [Cites] Am J Obstet Gynecol. 1997 Oct;177(4):870-4 [9369836.001]
  • [Cites] J Pediatr Surg. 2001 Aug;36(8):1244-7 [11479867.001]
  • [Cites] Surgery. 1976 Sep;80(3):297-305 [960000.001]
  • [Cites] Mayo Clin Proc. 1986 Jul;61(7):546-55 [3086634.001]
  • [Cites] Eur Radiol. 1998;8(1):100-2 [9442139.001]
  • [Cites] Pediatr Radiol. 2001 Oct;31(10):727-31 [11685443.001]
  • [Cites] Prog Pediatr Surg. 1981;14:225-39 [7221009.001]
  • [Cites] Cancer. 1997 Aug 15;80(4):681-90 [9264351.001]
  • [Cites] J Pediatr. 1974 Jul;85(1):139-40 [4852867.001]
  • [Cites] Anesthesiology. 1998 Dec;89(6):1573-5 [9856736.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2005 Nov;262(11):899-904 [15895292.001]
  • [Cites] Pediatr Surg Int. 2001 Mar;17(2-3):235-8 [11315301.001]
  • [Cites] Surg Today. 1994;24(10):923-5 [7894193.001]
  • [Cites] Am J Perinatol. 2001 Nov;18(7):357-62 [11731888.001]
  • [Cites] Am J Perinatol. 1992 Sep-Nov;9(5-6):445-7 [1418153.001]
  • [Cites] J Matern Fetal Med. 1999 Nov-Dec;8(6):295-7 [10582864.001]
  • [Cites] Cancer. 2003 Jan 15;97(2):367-76 [12518361.001]
  • [Cites] J Ultrasound Med. 1995 Sep;14 (9):673-8 [7500433.001]
  • [Cites] J Thorac Imaging. 1987 Apr;2(2):66-71 [3599151.001]
  • [Cites] J Pediatr Surg. 2002 Mar;37(3):418-26 [11877660.001]
  • (PMID = 16838188.001).
  • [ISSN] 0179-0358
  • [Journal-full-title] Pediatric surgery international
  • [ISO-abbreviation] Pediatr. Surg. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


70. Song JY, Kim SY, Park EG, Kim CJ, Kim DG, Lee HK, Park IY: Schwannoma in the retroperitoneum. J Obstet Gynaecol Res; 2007 Jun;33(3):371-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Schwannoma (neurilemmoma) is a peripheral nerve sheath tumor and commonly occurs singularly on the head, neck, and trunk.
  • The majority of symptoms caused by the tumor are due to the effect of its mass.
  • Surgical resection is enough to treat the tumor.
  • Schwannoma is reported usually as benign, and despite incomplete resection of the tumor, the risk of recurrence and metastasis is low.

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17578370.001).
  • [ISSN] 1341-8076
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 19
  •  go-up   go-down


71. Sevilla MA, Hermsen MA, Weiss MM, Grimbergen A, Balbín M, Llorente JL, Rodrigo JP, Suárez C: Chromosomal changes in sporadic and familial head and neck paragangliomas. Otolaryngol Head Neck Surg; 2009 May;140(5):724-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chromosomal changes in sporadic and familial head and neck paragangliomas.
  • OBJECTIVE: Paragangliomas (PGLs) of the head and neck are benign neoplasms derived from the autonomic nervous system.
  • The aim of this study was to compare somatic DNA copy number changes in tumors of familial and sporadic origin.
  • [MeSH-major] Head and Neck Neoplasms / genetics. Paraganglioma / genetics. Succinate Dehydrogenase / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Chi-Square Distribution. Comparative Genomic Hybridization. DNA Mutational Analysis. Female. Germ-Line Mutation. Humans. Male. Middle Aged. Proto-Oncogene Proteins c-ret / genetics. Von Hippel-Lindau Tumor Suppressor Protein / genetics

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19393419.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 1.3.99.1 / Succinate Dehydrogenase; EC 2.7.10.1 / Proto-Oncogene Proteins c-ret; EC 2.7.10.1 / RET protein, human; EC 6.3.2.19 / VHL protein, human; EC 6.3.2.19 / Von Hippel-Lindau Tumor Suppressor Protein
  •  go-up   go-down


72. Manzoor T, Ahmed B, Najam A, Ayub Z: Carotid body paraganglioma. J Coll Physicians Surg Pak; 2009 Aug;19(8):523-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Carotid body tumours are benign neoplasms.
  • This case report describes two patients with this rare tumour with diagnostic workup and treatment options.
  • The first case was a 36-year-old gentleman who presented with 6 months history of painless swelling on the left side of neck.
  • The second patient was 60-years-old man who presented with slowly growing swelling on the right side of neck for the last 20 years.
  • On suspicion of a vascular lesion, a contrast enhanced CT scan and Doppler's ultrasound of neck was advised which suggested the diagnosis of a carotid body tumour.
  • The second case was subjected to radiation therapy due to the large size of tumour and the patient's age.
  • [MeSH-major] Carotid Body / pathology. Carotid Body Tumor / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19651019.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Pakistan
  •  go-up   go-down


73. Mineva I, Gartner W, Hauser P, Kainz A, Löffler M, Wolf G, Oberbauer R, Weissel M, Wagner L: Differential expression of alphaB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific alphaB-crystallin gene (CRYAB) silencing. Cell Stress Chaperones; 2005;10(3):171-84
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential expression of alphaB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific alphaB-crystallin gene (CRYAB) silencing.
  • Expression of the small heat shock protein alphaB-crystallin in differentiated thyroid tumors has been described recently.
  • In this study, we investigated the molecular mechanisms that affect the expression of alphaB-crystallin in benign goiters (n = 7) and highly malignant anaplastic thyroid carcinomas (ATCs) (n = 3).
  • In contrast, considerable expression of Hsp27-1 in benign and malignant thyroid tissue was demonstrated.
  • Immunofluorescence analysis revealed no relevant topological differences between benign and malignant thyrocytes in the cytoplasmic staining of both proteins.
  • In conclusion, we demonstrate downregulation of alphaB-crystallin expression in highly dedifferentiated ATCs because of a tumor-specific transcription factor pattern.
  • [MeSH-minor] Animals. COS Cells. Cell Line, Tumor. Cloning, Molecular. DNA, Complementary / biosynthesis. Down-Regulation. Gene Silencing. Genes, Reporter. Goiter. HSP27 Heat-Shock Proteins. Heat-Shock Proteins / analysis. Heat-Shock Proteins / metabolism. Humans. Luciferases / genetics. Neoplasm Proteins / analysis. Neoplasm Proteins / metabolism. Oligonucleotide Array Sequence Analysis. Promoter Regions, Genetic. RNA, Messenger / metabolism. Tissue Extracts / chemistry. Tissue Extracts / genetics. Tissue Extracts / metabolism. Transfection. alpha-Crystallin B Chain

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):404-13 [15706087.001]
  • [Cites] J Physiol. 2005 May 1;564(Pt 3):715-22 [15718262.001]
  • [Cites] EMBO J. 1996 Jun 3;15(11):2695-706 [8654367.001]
  • [Cites] Eur J Biochem. 1996 Nov 15;242(1):56-66 [8954153.001]
  • [Cites] J Biol Chem. 2000 Jan 28;275(4):2852-8 [10644752.001]
  • [Cites] Nature. 2000 Aug 17;406(6797):747-52 [10963602.001]
  • [Cites] Nucleic Acids Res. 2001 Jan 1;29(1):152-5 [11125075.001]
  • [Cites] J Biol Chem. 2001 May 11;276(19):16059-63 [11274139.001]
  • [Cites] J Biol Chem. 2001 Feb 2;276(5):3324-32 [11073954.001]
  • [Cites] Biochim Biophys Acta. 2001 Jul 30;1520(1):1-6 [11470154.001]
  • [Cites] Biochem Biophys Res Commun. 2001 Aug 24;286(3):433-42 [11511077.001]
  • [Cites] J Biol Chem. 2002 Oct 11;277(41):38731-6 [12140279.001]
  • [Cites] Exp Eye Res. 2003 Feb;76(2):145-53 [12565801.001]
  • [Cites] Circ Res. 2003 Feb 7;92(2):130-2 [12574138.001]
  • [Cites] Thyroid. 2003 Mar;13(3):283-90 [12729478.001]
  • [Cites] Cell Stress Chaperones. 2003 Spring;8(1):53-61 [12820654.001]
  • [Cites] Head Neck. 2003 Aug;25(8):662-70 [12884350.001]
  • [Cites] Surg Oncol. 2003 Aug;12(2):69-90 [12946479.001]
  • [Cites] Cell Cycle. 2003 Nov-Dec;2(6):579-84 [14512773.001]
  • [Cites] N Engl J Med. 2003 Nov 20;349(21):2042-54 [14627790.001]
  • [Cites] Endocr Relat Cancer. 2004 Jun;11(2):377-89 [15163312.001]
  • [Cites] Cancer. 2004 Jun 15;100(12):2543-8 [15197794.001]
  • [Cites] Nucleic Acids Res. 1986 May 27;14(10):4127-45 [3714473.001]
  • [Cites] Proc Natl Acad Sci U S A. 1988 Dec;85(23):9302-6 [2848260.001]
  • [Cites] Mol Cell Biol. 1989 Mar;9(3):1083-91 [2725488.001]
  • [Cites] J Histochem Cytochem. 1990 Jan;38(1):31-9 [2294148.001]
  • [Cites] Genomics. 1990 Aug;7(4):594-601 [2387586.001]
  • [Cites] Exp Eye Res. 1992 Mar;54(3):461-70 [1381680.001]
  • [Cites] J Cell Biol. 1993 Feb;120(3):639-45 [8425893.001]
  • [Cites] Eur J Biochem. 1994 Oct 1;225(1):1-19 [7925426.001]
  • [Cites] J Pathol. 1994 Nov;174(3):209-15 [7823254.001]
  • [Cites] Hum Genet. 1996 Mar;97(3):299-303 [8786068.001]
  • [Cites] Cancer. 1995 Nov 1;76(9):1643-54 [8635070.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Jun 9;235(1):69-73 [9196037.001]
  • [Cites] J Cell Sci. 1997 Jul;110 ( Pt 13):1431-40 [9224761.001]
  • [Cites] Am J Physiol. 1998 May;274(5 Pt 2):H1457-64 [9612350.001]
  • [Cites] Genes Cells. 1998 Jul;3(7):443-57 [9753426.001]
  • [Cites] Am J Physiol. 1998 Dec;275(6 Pt 2):H2243-9 [9843825.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1999 Apr;40(5):951-8 [10102292.001]
  • [Cites] Prog Retin Eye Res. 1999 Jul;18(4):463-509 [10217480.001]
  • [Cites] Reproduction. 2005 Jan;129(1):115-26 [15615903.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1092-8 [15728570.001]
  • [Cites] Proteomics. 2005 Feb;5(3):788-95 [15682460.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1085-91 [15728569.001]
  • (PMID = 16184762.001).
  • [ISSN] 1355-8145
  • [Journal-full-title] Cell stress & chaperones
  • [ISO-abbreviation] Cell Stress Chaperones
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CRYAB protein, human; 0 / DNA, Complementary; 0 / HSP27 Heat-Shock Proteins; 0 / HSPB1 protein, human; 0 / Heat-Shock Proteins; 0 / Intermediate Filament Proteins; 0 / Neoplasm Proteins; 0 / Nerve Tissue Proteins; 0 / RNA, Messenger; 0 / Repressor Proteins; 0 / TFCP2L1 protein, human; 0 / Tissue Extracts; 0 / Transcription Factors; 0 / alpha-Crystallin B Chain; EC 1.13.12.- / Luciferases; EC 2.7.- / Protein Kinases
  • [Other-IDs] NLM/ PMC1226015
  •  go-up   go-down


74. Li JN, Feng CJ, Lu YJ, Li HJ, Tu Z, Liao GQ, Liang C: mRNA expression of the DNA replication-initiation proteins in epithelial dysplasia and squamous cell carcinoma of the tongue. BMC Cancer; 2008;8:395
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We analyzed the mRNA expression of CDC6, CDT1, MCM2 and CDC45 in formalin-fixed, paraffin-embedded benign and malignant tongue tissues using quantitative real-time PCR followed by statistical analysis.
  • The expression of the four genes is independent of tumor size or histological grade.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / genetics. DNA Replication. Epithelial Cells / metabolism. Epithelial Cells / pathology. Female. Gene Expression Regulation, Neoplastic. Humans. Male. Middle Aged. Minichromosome Maintenance Complex Component 2. RNA, Messenger / genetics. Young Adult

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 2007 Nov 15;67(22):10899-909 [18006835.001]
  • [Cites] FEBS J. 2007 Jul;274(14):3669-84 [17608804.001]
  • [Cites] J Cell Sci. 2001 Jun;114(Pt 11):2027-41 [11493639.001]
  • [Cites] Methods. 2001 Dec;25(4):409-18 [11846610.001]
  • [Cites] Oncogene. 2002 Feb 14;21(8):1150-8 [11850834.001]
  • [Cites] Pathobiology. 2001;69(3):150-8 [11872961.001]
  • [Cites] Annu Rev Biochem. 2002;71:333-74 [12045100.001]
  • [Cites] Cell. 2002 Jun 28;109(7):849-60 [12110182.001]
  • [Cites] CA Cancer J Clin. 2002 Jul-Aug;52(4):195-215 [12139232.001]
  • [Cites] Genes Dev. 2002 Oct 15;16(20):2639-49 [12381663.001]
  • [Cites] Curr Opin Plant Biol. 2002 Dec;5(6):480-6 [12393009.001]
  • [Cites] Eur J Biochem. 2003 Mar;270(6):1089-101 [12631269.001]
  • [Cites] Cancer Cell. 2003 Apr;3(4):311-6 [12726857.001]
  • [Cites] Cancer Res. 2003 Nov 1;63(21):7356-64 [14612534.001]
  • [Cites] Oncogene. 2004 May 6;23(21):3802-12 [14990995.001]
  • [Cites] Exp Mol Med. 2004 Apr 30;36(2):165-71 [15150445.001]
  • [Cites] Blood. 1997 Feb 1;89(3):965-74 [9028328.001]
  • [Cites] Lab Invest. 1998 Jan;78(1):73-8 [9461123.001]
  • [Cites] Mol Cell Biol. 1998 Nov;18(11):6679-97 [9774682.001]
  • [Cites] J Oral Pathol Med. 1998 Oct;27(9):434-40 [9790097.001]
  • [Cites] J Clin Pathol. 2005 May;58(5):525-34 [15858126.001]
  • [Cites] Head Neck. 2000 Jul;22(4):347-54 [10862017.001]
  • (PMID = 19116018.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CDC45 protein, human; 0 / CDC6 protein, human; 0 / CDT1 protein, human; 0 / Cell Cycle Proteins; 0 / Nuclear Proteins; 0 / RNA, Messenger; EC 3.6.4.12 / MCM2 protein, human; EC 3.6.4.12 / Minichromosome Maintenance Complex Component 2
  • [Other-IDs] NLM/ PMC2648984
  •  go-up   go-down


75. Ibekwe TS, Kokong DD, Ngwu BA, Akinyemi OA, Nwaorgu OG, Akang EE: Nasal septal teratoma in a child. World J Surg Oncol; 2007;5:58
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Teratoma is a rare developmental neoplasm that arises from totipotential tumor stem cells.
  • Head and neck teratomas constitute about 10% of all cases.
  • CONCLUSION: The prognosis for benign teratoma of the nasal septum is good following total surgical excision.

  • Genetic Alliance. consumer health - Teratoma.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ear Nose Throat J. 2000 Aug;79(8):620-3 [10969472.001]
  • [Cites] East Afr Med J. 2002 Feb;79(2):106-7 [12380890.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1972 Dec;81(6):848-53 [4636146.001]
  • [Cites] Pediatr Surg Int. 2006 Aug;22(8):627-34 [16838188.001]
  • [Cites] Laryngorhinootologie. 1996 Apr;75(4):239-41 [8688130.001]
  • [Cites] Med J Malaysia. 2004 Dec;59(5):678-9 [15889573.001]
  • [Cites] J Pediatr Surg. 2005 Nov;40(11):e31-4 [16291137.001]
  • [Cites] J Pediatr Surg. 1987 Feb;22(2):179-81 [3820022.001]
  • (PMID = 17540035.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1891297
  • [General-notes] NLM/ Original DateCompleted: 20070730
  •  go-up   go-down


76. Gerber PA, Schulte KW, Ruzicka T, Bruch-Gerharz D: Eccrine porocarcinoma of the head: an important differential diagnosis in the elderly patient. Dermatology; 2008;216(3):229-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Eccrine porocarcinoma is a rare malignant tumor of the sweat gland, characterized by a broad spectrum of clinicopathologic presentations.
  • Surprisingly, unlike its benign counterpart eccrine poroma, eccrine porocarcinoma is seldom found in areas with a high density of eccrine sweat glands, like the palms or soles.
  • Instead, eccrine porocarcinoma frequently occurs on the lower extremities, trunk and abdomen, but also on the head, resembling various other skin tumors, as illustrated in the patients described herein.
  • All patients were initially diagnosed as having epidermal or melanocytic skin tumors.
  • Only after histopathologic examination were they classified as eccrine porocarcinoma, showing features of epithelial tumors with abortive ductal differentiation.
  • Porocarcinomas are commonly overlooked, or misinterpreted as squamous or basal cell carcinomas as well as other common malignant and even benign skin tumors.
  • Knowledge of the clinical pattern and histologic findings, therefore, is crucial for an early therapeutic intervention, which can reduce the risk of tumor recurrence and serious complications.
  • [MeSH-major] Carcinoma, Skin Appendage / diagnosis. Eccrine Glands / pathology. Head and Neck Neoplasms / diagnosis. Sweat Gland Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18182815.001).
  • [ISSN] 1421-9832
  • [Journal-full-title] Dermatology (Basel, Switzerland)
  • [ISO-abbreviation] Dermatology (Basel)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


77. Park HS, Lee H, Moon WS, Lee SC, Choi WB, Choi HW: [Intussusception secondary to jejunal lymphangioma in a 13-year-old girl]. Korean J Gastroenterol; 2007 Apr;49(4):256-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lymphangioma is a benign tumor composed of numerous small or large thin-walled lymphatic spaces.
  • It shows a predilection for head, neck, and axilla.

  • Genetic Alliance. consumer health - Lymphangioma.
  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • MedlinePlus Health Information. consumer health - Small Intestine Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17464172.001).
  • [ISSN] 1598-9992
  • [Journal-full-title] The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
  • [ISO-abbreviation] Korean J Gastroenterol
  • [Language] kor
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Korea (South)
  •  go-up   go-down


78. Hussein HA, Mebeed AH, Saber TKh, Farhat IG: Hyperparathyroidism with bone tumor-like presentation, approach for diagnosis and surgical intervention. J Egypt Natl Canc Inst; 2009 Mar;21(1):1-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hyperparathyroidism with bone tumor-like presentation, approach for diagnosis and surgical intervention.
  • AIM OF WORK: This work aims to find out a clinical approach for diagnosis of cases with hyperparathyroidism presented with bone tumor like condition as first and main presentation in order to differentiate primary bone tumors or secondary bone metastases from different types of hyperparathyroidism and to clear out the indications and type of surgery in such cases.
  • During this period we followed 45 cases of hyperparathyroidism (HPT) presented with a main complaint of bone tumor-like lesion.
  • We started by clinical evaluation, laboratory investigationsincluding: Parathormone hormone, total and ionic calcium, renal function tests, alkaline phosphatase, 24h urine calcium, C-AMP in urine or inappropriate parathormne like peptide if needed and radiological investigations for preoperative localization including neck ultrasound, Tc99m Sestamibi scan, C-T neck and superior mediastinum or M.R.I.
  • RESULTS: Preoperative diagnosis was: 80% cases of primary hyperparathyroidism (pHPT), 15.5% cases of secondary hyperparathyroidism (sHPT), 4.5% tertiary hyperparathyroidism (tHPT), benign adenoma in 73.3%, diffuse hyperplasia in 8.8% and one case of parathyroid carcinoma.
  • Neck ultrasound localized 29/38 adenoma (sensitivity = 73.3%), sestamibi localized 23/38 including another 2 cases of diffuse hyperplasia not detected by ultrasound (sensitivity = 63.8%), C-T scan detected adenoma in upper mediastinum.
  • CONCLUSION: Hyperparathyroidism should be suspected in all cases with bone tumor-like presentation or even in earlier disease complain of bony or muscle aches.
  • Intact P.T.H and calcium (total &ionic), renal functions, 24 hours urine calcium, neck ultrasonography, and Tc 99m pertechnitate/Tc99m sestsmibi subtraction scan can establish the diagnosis.
  • KEY WORDS: Hyperparathyroidism - Bone tumor-like presentation - Diagnosis - Surgical approach.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20601966.001).
  • [ISSN] 1110-0362
  • [Journal-full-title] Journal of the Egyptian National Cancer Institute
  • [ISO-abbreviation] J Egypt Natl Canc Inst
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  •  go-up   go-down


79. Pagedar NA, Chen DH, Wasman JK, Savvides P, Schluchter MD, Wilhelm SM, Lavertu P: Molecular classification of thyroid nodules by cytology. Laryngoscope; 2008 Apr;118(4):692-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recent studies have characterized differences in gene expression between benign and malignant conditions, most often using whole tissue.
  • [MeSH-minor] Adenocarcinoma, Follicular / pathology. Adenoma / pathology. Antigens, CD3 / analysis. Antigens, Neoplasm / analysis. Biomarkers, Tumor / analysis. Biopsy, Fine-Needle. Carcinoma, Papillary / pathology. Cell Adhesion Molecules / analysis. Feasibility Studies. Fibronectins / analysis. Galectin 3 / analysis. Gene Expression Regulation, Neoplastic / genetics. Goiter / pathology. Humans. Molecular Biology. Mucin-1 / analysis. Polymerase Chain Reaction. Prospective Studies. Protein-Tyrosine Kinases / analysis. Proto-Oncogene Proteins / analysis. Proto-Oncogene Proteins c-met. Receptors, Growth Factor / analysis. Reverse Transcriptase Polymerase Chain Reaction. Thyroid Neoplasms / pathology

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18094649.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD3; 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Cell Adhesion Molecules; 0 / Fibronectins; 0 / Galectin 3; 0 / MUC1 protein, human; 0 / Mucin-1; 0 / Proto-Oncogene Proteins; 0 / Receptors, Growth Factor; 0 / tumor-associated antigen GA733; EC 2.7.10.1 / MET protein, human; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Proto-Oncogene Proteins c-met
  •  go-up   go-down


80. Pisanu A, Di Chiara B, Reccia I, Uccheddu A: Oncocytic cell tumors of the thyroid: factors predicting malignancy and influencing prognosis, treatment decisions, and outcomes. World J Surg; 2010 Apr;34(4):836-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oncocytic cell tumors of the thyroid: factors predicting malignancy and influencing prognosis, treatment decisions, and outcomes.
  • BACKGROUND: The distinction between malignant and benign thyroid oncocytic cell tumors (OCTs) before and during surgery still represents a diagnostic challenge.
  • A cross-sectional study of 28 patients with carcinoma and 29 patients with adenoma was performed: demographic data, tumor characteristics, diagnostic results, patient management, postoperative, and follow-up results were evaluated.
  • The mean tumor size was significantly greater for carcinomas than for adenomas (3.0 cm vs. 1.8 cm; p = 0.003).
  • Tumor multifocality, microfollicular features, and severe cytological atypia also were significantly related to malignancy (p = 0.012 and p = 0.025, respectively).
  • Older age, tumor size, thyroid capsular invasion, higher TNM stage, and AMES high risk were factors significantly related to tumor recurrence.
  • Multivariate analysis showed that larger tumor size was the only factor predictive of malignancy and influencing recurrence.
  • In the case of OCTs with larger tumor size and microfollicular features with severe cytological atypia, total thyroidectomy is strongly recommended as initial treatment also in relation with the more likely aggressive biological behavior of greater tumors.
  • [MeSH-minor] Adenoma / epidemiology. Adenoma / pathology. Adenoma / surgery. Adult. Aged. Carcinoma / epidemiology. Carcinoma / pathology. Carcinoma / surgery. Cross-Sectional Studies. Decision Making. Diagnosis, Differential. Female. Humans. Italy / epidemiology. Logistic Models. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Recurrence, Local. Neoplasm Staging. Predictive Value of Tests. Prevalence. Prognosis. Risk Factors. Survival Analysis. Thyroidectomy

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg Oncol. 2002 Mar;9(2):197-203 [11888879.001]
  • [Cites] Diagn Cytopathol. 2006 May;34(5):330-4 [16604553.001]
  • [Cites] World J Surg. 2005 Feb;29(2):164-8 [15650796.001]
  • [Cites] Surgery. 2005 Oct;138(4):650-6; discussion 656-7 [16269293.001]
  • [Cites] Ann Surg. 2001 May;233(5):716-22 [11323510.001]
  • [Cites] Otolaryngol Clin North Am. 1990 Jun;23 (3):441-52 [2195433.001]
  • [Cites] Surgery. 2003 Dec;134(6):881-9; discussion 889 [14668719.001]
  • [Cites] J Nucl Med. 2006 Aug;47(8):1260-6 [16883003.001]
  • [Cites] J Clin Endocrinol Metab. 1988 Sep;67(3):501-8 [3410936.001]
  • [Cites] Surgery. 1986 Dec;100(6):1108-15 [3787466.001]
  • [Cites] Am J Surg. 2006 May;191(5):593-7 [16647343.001]
  • [Cites] Surgery. 1985 Oct;98(4):777-83 [4049249.001]
  • [Cites] Cancer. 2006 Apr 25;108(2):102-9 [16453320.001]
  • [Cites] Int Surg. 1989 Apr-Jun;74(2):97-8 [2753630.001]
  • [Cites] Surgery. 1985 Dec;98(6):1171-8 [4071392.001]
  • [Cites] Am J Clin Pathol. 1988 Jun;89(6):764-9 [3369368.001]
  • [Cites] Surg Gynecol Obstet. 1974 Oct;139(4):555-60 [4479589.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Dec;83(12):4195-203 [9851751.001]
  • [Cites] Cancer. 1998 Dec 15;83(12):2638-48 [9874472.001]
  • [Cites] Cancer. 2002 Oct 25;96(5):261-6 [12378592.001]
  • [Cites] Ann Surg. 1981 Dec;194(6):677-80 [7305479.001]
  • [Cites] Surgery. 1985 Dec;98(6):1162-5 [4071391.001]
  • [Cites] Thyroid. 2003 Jun;13(6):577-84 [12930602.001]
  • [Cites] Eur J Surg Oncol. 2006 May;32(4):458-61 [16497473.001]
  • [Cites] Cancer. 1991 Nov 1;68(9):1944-53 [1913544.001]
  • [Cites] Arch Surg. 1997 Jun;132(6):674-8; discussion 678-80 [9197862.001]
  • [Cites] Cancer. 2000 Jul 1;89(1):202-17 [10897019.001]
  • [Cites] Surgery. 2007 Dec;142(6):952-8; discussion 952-8 [18063081.001]
  • [Cites] Ann Surg. 1998 Apr;227(4):542-6 [9563543.001]
  • [Cites] Cancer. 2003 Mar 1;97(5):1186-94 [12599224.001]
  • [Cites] Thyroid. 2002 Feb;12 (2):155-61 [11916285.001]
  • [Cites] Chirurgie. 1996;121(1):28-36 [8761701.001]
  • [Cites] Cancer Control. 1997 Jan;4(1):13-17 [10762998.001]
  • [Cites] Am J Clin Pathol. 1993 Sep;100(3):231-5 [8379531.001]
  • [Cites] Ann Surg Oncol. 2008 Oct;15(10):2842-6 [18665423.001]
  • [Cites] Head Neck. 1999 Sep;21(6):506-11 [10449665.001]
  • [Cites] Am Surg. 1998 Aug;64(8):729-32; discussion 732-3 [9697901.001]
  • [Cites] Diagn Cytopathol. 2004 Nov;31(5):307-12 [15468114.001]
  • [Cites] J Am Coll Surg. 1998 Nov;187(5):494-502 [9809565.001]
  • [Cites] Mod Pathol. 2000 Feb;13(2):186-92 [10697277.001]
  • [Cites] World J Surg. 2001 Sep;25(9):1160-3 [11571953.001]
  • [Cites] Surgery. 1995 Oct;118(4):711-4; discussion 714-5 [7570326.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1067-72 [12829143.001]
  • [Cites] Diagn Cytopathol. 2008 Mar;36(3):149-54 [18232004.001]
  • [Cites] J Exp Clin Cancer Res. 1998 Mar;17(1):103-7 [9646243.001]
  • [Cites] World J Surg. 2004 Aug;28(8):761-5 [15457355.001]
  • [Cites] Laryngoscope. 2002 Dec;112(12):2178-80 [12461336.001]
  • [Cites] Am J Surg. 1996 Dec;172(6):692-4 [8988680.001]
  • [Cites] World J Surg. 2008 May;32(5):702-7 [18224463.001]
  • [Cites] Arch Surg. 1983 May;118(5):529-32 [6838358.001]
  • [Cites] JAMA. 1984 Jun 15;251(23):3114-7 [6726982.001]
  • [Cites] Head Neck. 1993 Jul-Aug;15(4):335-41 [8360056.001]
  • [Cites] Ann Surg. 1995 Jul;222(1):101-6 [7618962.001]
  • [Cites] Am J Surg. 2008 Apr;195(4):457-62 [18070728.001]
  • [Cites] Surgery. 1996 Dec;120(6):1000-4; discussion 1004-5 [8957486.001]
  • [Cites] Surgery. 1999 Oct;126(4):798-802; discussion 802-4 [10520931.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):54-8 [16415430.001]
  • [Cites] World J Surg. 2004 Dec;28(12):1266-70 [15517492.001]
  • (PMID = 20041243.001).
  • [ISSN] 1432-2323
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


81. Gu TF, Xiao XL, Sun F, Yin JH, Zhao H: Diagnostic value of whole body diffusion weighted imaging for screening primary tumors of patients with metastases. Chin Med Sci J; 2008 Sep;23(3):145-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnostic value of whole body diffusion weighted imaging for screening primary tumors of patients with metastases.
  • OBJECTIVE: To evaluate the values of whole body diffusion weighted imaging (DWI) in screening primary unknown tumor in patients with metastases.
  • METHODS: Totally, 34 patients with metastases of primary unknown tumors were scanned with whole body DWI, and conventional magnetic resonance (MR) imaging was performed if suspected lesions were detected.
  • All the metastases including 27 cases of osseous metastases, 2 brain metastases, 2 liver metastases, 1 pulmonary multiple metastasis, 1 neck metastasis and 1 malignant ascites, were diagnosed by computed tomography, single photon emission computed tomography, or MR imaging.
  • For the proven primary tumors diagnosed by biopsy or pathology of surgical specimens, apparent diffusion coefficient (ADC) values of the primary and metastatic lesions were measured respectively.
  • The sensitivity and specificity of this technique for screening primary tumors were evaluated.
  • RESULTS: We found 24 cases with suspected primary lesions, in which 23 lesions were proved to be primary tumors, and 1 was proved to be benign lesion.
  • And no definite primary lesion was found in 10 cases on whole body DWI, but in which 1 case was diagnosed with primary tumor by biopsy later, and the other 9 cases remained unknown within follow-up of over half a year.
  • The sensitivity and specificity of whole body DWI for searching primary tumors was 95.8% and 90.0%, respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18853848.001).
  • [ISSN] 1001-9294
  • [Journal-full-title] Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
  • [ISO-abbreviation] Chin. Med. Sci. J.
  • [Language] ENG
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] China
  •  go-up   go-down


82. Coutinho-Camillo CM, Brentani MM, Nagai MA: Genetic alterations in juvenile nasopharyngeal angiofibromas. Head Neck; 2008 Mar;30(3):390-400
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Juvenile nasopharyngeal angiofibroma (JNA) is a rare benign neoplasm of the nasopharynx that accounts for 0.5% of all head and neck tumors.
  • Although histologically benign in appearance, JNAs are locally aggressive and destructive, spreading from the nasal cavity to the nasopharynx, paranasal sinuses, and orbit skull base with intracranial extension.
  • Hormonal disorders have been reported in patients with JNA, and androgen and estrogen receptors have been identified in tumor tissue; however, a hormonal influence on JNA is controversial.
  • Understanding of the molecular mechanisms involved in JNA might improve prevention, prognosis, and treatment of this tumor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley Periodicals, Inc. Head Neck, 2008.
  • (PMID = 18228521.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Intercellular Signaling Peptides and Proteins; 0 / RNA, Messenger; 0 / Receptors, Steroid; 0 / beta Catenin; EC 2.5.1.18 / Glutathione Transferase
  • [Number-of-references] 103
  •  go-up   go-down


83. Sadick H, Goepel B, Bersch C, Goessler U, Hoermann K, Riedel F: Rhinophyma: diagnosis and treatment options for a disfiguring tumor of the nose. Ann Plast Surg; 2008 Jul;61(1):114-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rhinophyma: diagnosis and treatment options for a disfiguring tumor of the nose.
  • Rhinophyma is a benign dermatologic disease of the nose affecting primarily Caucasian men in their fifth to seventh decades of life.
  • Surgical removal of the hyperplastic tumor mass is the treatment of choice for rhinophyma.

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18580161.001).
  • [ISSN] 1536-3708
  • [Journal-full-title] Annals of plastic surgery
  • [ISO-abbreviation] Ann Plast Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 51
  •  go-up   go-down


84. Kross KW, Heimdal JH, Olsnes C, Olofsson J, Aarstad HJ: Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis. Scand J Immunol; 2008 Apr;67(4):392-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis.
  • Co-culture of monocytes with autologous fragment (F) spheroids originating from malignant (M) tumour or benign (B) control mucosa of head and neck squamous cell carcinoma (HNSCC) yields interleukin (IL)-6 and monocyte chemo-attractant protein (MCP)-1 secretion.
  • [MeSH-major] Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / immunology. Head and Neck Neoplasms / diagnosis. Head and Neck Neoplasms / immunology. Monocytes / immunology
  • [MeSH-minor] Biomarkers / metabolism. Chemokine CCL2 / metabolism. Coculture Techniques. Humans. Interleukin-6 / metabolism. Prognosis. Recurrence. Spheroids, Cellular. Tumor Cells, Cultured


85. Zhang B, Chen W, Roman A: The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci U S A; 2006 Jan 10;103(2):437-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • High-risk human papillomaviruses (HPVs) (e.g., HPV-16) cause anogenital and head and neck cancers, and low-risk HPVs (e.g., HPV-6) cause benign hyperproliferative disease.
  • The E7 protein of HPV-16 binds all retinoblastoma tumor suppressor protein (pRB) family members with higher affinity than HPV-6E7.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2003 Nov 21;278(47):46482-7 [12968030.001]
  • [Cites] Cancer Cell. 2003 Apr;3(4):311-6 [12726857.001]
  • [Cites] J Virol. 2004 Apr;78(7):3533-41 [15016876.001]
  • [Cites] Microbiol Mol Biol Rev. 2004 Jun;68(2):362-72 [15187189.001]
  • [Cites] Mol Cell Biol. 2004 Oct;24(20):8970-80 [15456871.001]
  • [Cites] Virology. 2004 Nov 10;329(1):189-98 [15476886.001]
  • [Cites] Science. 1989 Feb 17;243(4893):934-7 [2537532.001]
  • [Cites] EMBO J. 1989 Dec 20;8(13):4099-105 [2556261.001]
  • [Cites] J Virol. 1990 Feb;64(2):723-30 [2153238.001]
  • [Cites] J Virol. 1991 Dec;65(12):6922-30 [1834862.001]
  • [Cites] J Virol. 1992 Apr;66(4):2125-34 [1312623.001]
  • [Cites] J Virol. 1992 Apr;66(4):2418-27 [1312637.001]
  • [Cites] Oncogene. 1992 Apr;7(4):619-26 [1314365.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 May 15;89(10):4442-6 [1316608.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 May 15;89(10):4549-53 [1316611.001]
  • [Cites] J Gen Virol. 1992 May;73 ( Pt 5):1275-9 [1316945.001]
  • [Cites] Biochem Biophys Res Commun. 1993 May 14;192(3):1380-7 [8389548.001]
  • [Cites] Mol Cell Biol. 1993 Nov;13(11):7029-35 [8413292.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 May 10;91(10):4382-6 [8183918.001]
  • [Cites] Oncogene. 1994 Sep;9(9):2633-8 [8058327.001]
  • [Cites] J Virol. 1994 Nov;68(11):7051-9 [7933087.001]
  • [Cites] Genes Dev. 1995 Oct 1;9(19):2335-49 [7557386.001]
  • [Cites] J Virol. 1996 Oct;70(10):6862-9 [8794328.001]
  • [Cites] Cancer Res. 1996 Oct 15;56(20):4620-4 [8840974.001]
  • [Cites] J Virol. 1997 Apr;71(4):2905-12 [9060648.001]
  • [Cites] Mol Cell Biol. 1997 Aug;17(8):4761-73 [9234732.001]
  • [Cites] Mol Cell Biol. 1997 Sep;17(9):4979-90 [9271376.001]
  • [Cites] Genes Dev. 1997 Aug 15;11(16):2101-11 [9284049.001]
  • [Cites] J Virol. 1997 Dec;71(12):9410-6 [9371601.001]
  • [Cites] Virology. 1997 Dec 8;239(1):238-46 [9426463.001]
  • [Cites] Virology. 1998 Jul 20;247(1):74-85 [9683573.001]
  • [Cites] Cell Growth Differ. 1998 Aug;9(8):585-93 [9716176.001]
  • [Cites] EMBO J. 1999 May 4;18(9):2449-58 [10228159.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8449-54 [10411895.001]
  • [Cites] Oncogene. 2005 Apr 18;24(17):2796-809 [15838516.001]
  • [Cites] Oncogene. 1999 Dec 20;18(55):7873-82 [10630640.001]
  • [Cites] Genes Dev. 2000 Apr 1;14(7):804-16 [10766737.001]
  • [Cites] J Virol. 2000 Jul;74(14):6622-31 [10864676.001]
  • [Cites] Exp Cell Res. 2001 Mar 10;264(1):135-47 [11237530.001]
  • [Cites] J Virol. 2001 May;75(10):4705-12 [11312342.001]
  • [Cites] J Virol. 2001 Aug;75(15):6737-47 [11435552.001]
  • [Cites] J Virol. 2001 Aug;75(16):7583-91 [11462030.001]
  • [Cites] J Virol. 2002 Jan;76(1):220-31 [11739687.001]
  • [Cites] Mol Cell Biol. 2002 Jan;22(2):453-68 [11756542.001]
  • [Cites] Genes Dev. 2002 Apr 15;16(8):933-47 [11959842.001]
  • [Cites] Nat Rev Cancer. 2002 May;2(5):342-50 [12044010.001]
  • [Cites] Genes Dev. 2002 Nov 15;16(22):2946-57 [12435635.001]
  • [Cites] Carcinogenesis. 2003 Feb;24(2):159-69 [12584163.001]
  • [Cites] Development. 2003 Jun;130(11):2341-53 [12702649.001]
  • [Cites] J Virol. 2004 Mar;78(5):2620-6 [14963169.001]
  • (PMID = 16381817.001).
  • [ISSN] 0027-8424
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI049254; United States / NIAID NIH HHS / AI / AI49254
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Culture Media; 0 / Oncogene Proteins, Viral; 0 / Papillomavirus E7 Proteins; 0 / Retinoblastoma-Like Protein p130; 0 / oncogene protein E7, Human papillomavirus type 16; 0 / oncogene protein E7, Human papillomavirus type 6; EC 3.4.25.1 / Proteasome Endopeptidase Complex
  • [Other-IDs] NLM/ PMC1326189
  •  go-up   go-down


86. Offman S, Pasternak S, Walsh N: Keloidal and other collagen patterns in atypical fibroxanthomas. Am J Dermatopathol; 2010 Jun;32(4):326-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It can represent (1) a mesenchymal component of a biphasic tumor, (2) a desmoplastic host response to a neoplasm, or (3) a product of the tumor cells.
  • In regard to atypical fibroxanthoma (AFX), conventional wisdom holds that intratumoral collagen is not commonly observed, apart from the rare sclerotic subtype of the neoplasm.
  • The majority of the cases (92%) were located on the head or neck.
  • The conventional pleomorphic subtype of the tumor was encountered most frequently (67%).
  • (1) Is the collagen part of a host response to the neoplasm or is it a product of the tumor cells?
  • (3) Does it signify an involutional stage of the tumor and imply a favorable prognosis?
  • (4) Is it related to the "sclerotic" variant of the tumor?
  • We discuss the above quandaries and emphasize the need to register this variant of AFX amongst other morphological subtypes of the tumor.
  • [MeSH-major] Collagen. Histiocytoma, Benign Fibrous / pathology. Keloid / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20514669.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 9007-34-5 / Collagen
  •  go-up   go-down


87. Rong BG, Chen WL, Ding YP, Xie G, Chen Y, Wang TD: [Surgical approaches to the skull base neoplasms]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Apr;40(4):291-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Eleven surgical approaches including midfacial degloving, frontal coronal discission, nasal eversion, maxillary swing, partial maxillary resection, total resection of orbit, mandibular swing, combination of front, temple, preauricular, post aureum, neck, and transoral approaches were used to resect the tumor which involved fossae pterygopalatine, paranasal sinuses, nasopharynx, antero, meso and posterobasilar region, lobi frontalis and lobi temporalis of cerebrum.
  • In 29 patients with benign tumor including 11 cases of meningioma, 3 cases of chondroma, 1 case of hemangio-meningioma, 1 case of cavernous hemangioma, 2 cases of osteodysplasia fibromas, 9 cases of neurofibroma, 1 case of glomus jugular tumor, 1 case of neurilemmoma, 19 have survived over 5 years and the longest one has survived over 8 years.
  • For 50 patients with malignant tumor including 3 cases of well-differentiated squamous cell carcinoma, 17 cases of moderately differentiated squamous cell carcinoma, 11 cases of poorly differentiated squamous cell carcinoma, 1 case of undifferentiated carcinoma, 2 cases of chondrosarcoma, 5 cases of canceration of papilloma, 2 cases of adenocarcinoma, 1 case of esthesioneuroblastoma, 2 cases of malignant fibrohistiocytoma, 1 case of fibrosarcoma, 2 cases of malignant mixed tumour, 3 cases of sarcoma survival rates of 3 and 5 years were 59.2% (29/49), 38.5% (10/26) respectively.
  • CONCLUSION: In order to resect the tumor completely and reduce the complication and malformation as far as possible, different surgical approaches must be designed according to the pathological changes characters and involved area,and the surgeon should select the shortest approach, avoid to damage the important neurovascular structure, and resect the tumor through the natural anatomy space by the shelter incision.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16008265.001).
  • [ISSN] 1673-0860
  • [Journal-full-title] Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • [ISO-abbreviation] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


88. Tokyol C, Aktepe F, Yavas BD, Yildiz H, Aycicek A: Chondroid syringoma: a case report. Acta Cytol; 2010 Sep-Oct;54(5 Suppl):973-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Chondroid syringoma is a benign skin adnexal tumor.
  • The reported incidence of chondroid syringoma among primary skin tumors is low and has been reported at 0.01-0.098%.
  • A diagnosis of benign appendageal tumor of the skin was made.
  • Surgical excision of tumor was done.
  • CONCLUSION: Chondroid syringoma should be included in the differential diagnosis of a slowly growing nodule on the head or neck.

  • Genetic Alliance. consumer health - Syringoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21053580.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


89. Dellian M: [Mass in the neck--the view of the ENT specialist]. MMW Fortschr Med; 2005 Mar 3;147(9):26-7, 29-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Mass in the neck--the view of the ENT specialist].
  • A swelling in the neck is a common finding.
  • Underlying causes may be enlarged lymph nodes and cysts, but also benign and malignant tumors.
  • In adults older than 40, however, a malignant tumor may be expected in more that 50% of the cases.
  • Sine early detection is associated with a good prognosis, every mass in the neck must be considered to be potentially malignant.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Hodgkin Disease / diagnosis. Lymphadenitis / diagnosis. Otolaryngology. Patient Care Team. Respiratory Tract Infections / diagnosis

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15794350.001).
  • [ISSN] 1438-3276
  • [Journal-full-title] MMW Fortschritte der Medizin
  • [ISO-abbreviation] MMW Fortschr Med
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


90. Chung SW, Kwon SY, Jung KY, Woo JS: Synchronous double primary cancers of the unilateral parotid gland. Acta Otolaryngol; 2007 Feb;127(2):209-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A review of the literature revealed that most reported cases were either a combination of two distinct benign neoplasms or a benign neoplasm and another malignant tumor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17364354.001).
  • [ISSN] 0001-6489
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Norway
  •  go-up   go-down


91. Tanaka H, Yamazaki N, Kawabe M, Watanabe H, Nakade M: [Subpectoral lipoma developing to cervix; report of a case]. Kyobu Geka; 2010 Mar;63(3):248-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Subpectoral lipoma is one of the benign tumor and at the operation less invasive and cosmetically superior approach should be adopted except for inevitable cases.
  • [MeSH-major] Head and Neck Neoplasms / pathology. Lipoma / pathology. Soft Tissue Neoplasms / pathology. Thoracic Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20214358.001).
  • [ISSN] 0021-5252
  • [Journal-full-title] Kyobu geka. The Japanese journal of thoracic surgery
  • [ISO-abbreviation] Kyobu Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


92. Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E: Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med; 2009 Jul 23;361(4):358-67
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Profound hearing loss is a serious complication of neurofibromatosis type 2, a genetic condition associated with bilateral vestibular schwannomas, benign tumors that arise from the eighth cranial nerve.
  • There is no medical treatment for such tumors.
  • An imaging response was defined as a decrease of at least 20% in tumor volume, as compared with baseline.
  • RESULTS: VEGF was expressed in 100% of vestibular schwannomas and VEGFR-2 in 32% of tumor vessels on immunohistochemical analysis.
  • Before treatment, the median annual volumetric growth rate for 10 index tumors was 62%.
  • After bevacizumab treatment in the 10 patients, tumors shrank in 9 patients, and 6 patients had an imaging response, which was maintained in 4 patients during 11 to 16 months of follow-up.

  • Genetic Alliance. consumer health - Neurofibromatosis.
  • Genetic Alliance. consumer health - Neurofibromatosis type 2.
  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2009 Massachusetts Medical Society
  • [CommentIn] N Engl J Med. 2009 Oct 29;361(18):1810; author reply 1810-1 [19877310.001]
  • [CommentIn] N Engl J Med. 2009 Oct 29;361(18):1809-10; author reply 1810-1 [19864683.001]
  • (PMID = 19587327.001).
  • [ISSN] 1533-4406
  • [Journal-full-title] The New England journal of medicine
  • [ISO-abbreviation] N. Engl. J. Med.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P01 CA080124; United States / NINDS NIH HHS / NS / P01 NS024279; United States / NCI NIH HHS / CA / P01CA80124; United States / NINDS NIH HHS / NS / P01NS024279
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Neuropilin-2; 0 / Vascular Endothelial Growth Factor A; 144713-63-3 / Neuropilin-1; 2S9ZZM9Q9V / Bevacizumab; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-2
  • [Other-IDs] NLM/ NIHMS765691; NLM/ PMC4816642
  •  go-up   go-down


93. Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, Pacak K: High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing. J Clin Endocrinol Metab; 2006 Nov;91(11):4505-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONTEXT: Adrenal and extraadrenal paragangliomas are tumors of chromaffin cells that are usually benign but that may also develop into malignant disease.
  • Close to one third of patients had metastases originating from an adrenal primary tumor, compared with a little over two thirds from an extraadrenal tumor.
  • [MeSH-minor] Abdominal Neoplasms / genetics. Abdominal Neoplasms / secretion. Adolescent. Adult. Aged. Aged, 80 and over. Child. Female. Gene Frequency. Germ-Line Mutation. Head and Neck Neoplasms / genetics. Head and Neck Neoplasms / secretion. Humans. Male. Middle Aged. Paraganglioma, Extra-Adrenal / genetics. Paraganglioma, Extra-Adrenal / secretion. Polymorphism, Genetic

  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • MedlinePlus Health Information. consumer health - Genetic Testing.
  • COS Scholar Universe. author profiles.
  • SciCrunch. OMIM: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16912137.001).
  • [ISSN] 0021-972X
  • [Journal-full-title] The Journal of clinical endocrinology and metabolism
  • [ISO-abbreviation] J. Clin. Endocrinol. Metab.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Catecholamines; 0 / Iron-Sulfur Proteins; EC 1.3.5.1 / SDHB protein, human; EC 1.3.99.1 / Succinate Dehydrogenase
  •  go-up   go-down


94. Jang YW, Kim SG, Pai H, Park JW, Lee YC, Rotaru H: Sialolipoma: case report and review of 27 cases. Oral Maxillofac Surg; 2009 Jun;13(2):109-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: This article presents a patient with sialolipoma of the submandibular gland, a rare neoplasm, and reviews related literatures.
  • The most common site for the tumor was the parotid gland (17 cases, 60.7%), followed by the palate (four cases, 14.2%).
  • Histopathologically, a tumor was a benign lesion with proliferating lipocytes including scattered foci with a normal salivary gland tissue.
  • CONCLUSION: Sialolipoma is a rare benign neoplasm in the head and neck and it shows equal sex predilection.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Surg Oral Med Oral Pathol. 1973 Oct;36(4):551-7 [4580925.001]
  • [Cites] Ann Diagn Pathol. 2006 Apr;10(2):72-6 [16546040.001]
  • [Cites] J Laryngol Otol. 1993 Mar;107(3):257-8 [8509709.001]
  • [Cites] Br J Oral Maxillofac Surg. 1995 Jun;33(3):196-7 [7654668.001]
  • [Cites] Otolaryngol Head Neck Surg. 2000 Mar;122(3):461-2 [10699830.001]
  • [Cites] Histopathology. 2001 Jan;38(1):30-6 [11135044.001]
  • [Cites] Arch Otolaryngol. 1976 Apr;102(4):230-2 [1267707.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Oct;98(4):441-50 [15472660.001]
  • [Cites] Beitr Pathol Anat. 1959;121:64-80 [14444615.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1966 Jun;21(6):770-7 [5219667.001]
  • [Cites] J Oral Pathol Med. 1994 May;23(5):237-9 [8046661.001]
  • [Cites] Pathol Res Pract. 1999;195(4):247-52 [10337663.001]
  • [Cites] Int J Oral Maxillofac Surg. 2003 Feb;32(1):49-53 [12653233.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Dec;104(6):809-13 [17482843.001]
  • [Cites] Pediatr Dev Pathol. 2007 May-Jun;10 (3):244-6 [17535092.001]
  • [Cites] J Oral Maxillofac Surg. 1991 Nov;49(11):1231-6 [1941342.001]
  • (PMID = 19347375.001).
  • [ISSN] 1865-1550
  • [Journal-full-title] Oral and maxillofacial surgery
  • [ISO-abbreviation] Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 16
  •  go-up   go-down


95. Vandergriff TW, Reed JA, Orengo IF: An unusual presentation of atypical fibroxanthoma. Dermatol Online J; 2008;14(1):6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Atypical fibroxanthoma (AFX) is a rare cutaneous spindle-cell neoplasm.
  • The tumor occurs most commonly in sun-damaged skin of the head and neck in elderly patients.
  • [MeSH-major] Histiocytoma, Benign Fibrous / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18319023.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Souza DP, Loureiro CC, Rejas RA, Sousa SO, Raitz R: Intraosseous myofibroma simulating an odontogenic lesion. J Oral Sci; 2009 Jun;51(2):307-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Myofibroma is a rare benign nodular tumor of the soft tissues, bones, or internal organs, and may affect both children and adults.
  • It is mostly found in the head and neck region, although uncommon in the jaw bones, where only a few lesions have been described.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19550103.001).
  • [ISSN] 1880-4926
  • [Journal-full-title] Journal of oral science
  • [ISO-abbreviation] J Oral Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Actins; 0 / Vimentin
  •  go-up   go-down


97. Chiu AG, Jackman AH, Antunes MB, Feldman MD, Palmer JN: Radiographic and histologic analysis of the bone underlying inverted papillomas. Laryngoscope; 2006 Sep;116(9):1617-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Inverted papilloma (IP) is a benign but locally aggressive sinonasal tumor.
  • Successful endoscopic management is based on accurate intraoperative identification and complete resection of the tumor.
  • Intraoperatively, the site of tumor attachment was identified, and a 1- to 2-cm wedge of bone with overlying tumor was removed en bloc and analyzed under light microscopy.
  • Preoperative radiographic studies were analyzed with respect to bony changes in the area of the tumor pedicle.
  • Radiographic osteitic bony changes were seen at site of tumor attachment in 100% of cases.
  • CONCLUSION: The irregularity of the bony surface may hinder complete tumor removal because microscopic rests of mucosa can be hidden within the bony crevices.
  • Intraoperative removal of the bony surface at the site of tumor attachment may ensure a more complete removal.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16954991.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


98. Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y: Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg; 2010 Jun;34(6):1222-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Papillary microcarcinoma (PMC) of the thyroid generally follows a benign clinical course.
  • Three patients (1%) who developed apparent lymph node metastasis and nine patients (4%) in whom tumor increased in size eventually received surgery after 1-12 years of follow-up.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chi-Square Distribution. Female. Humans. Iodine Radioisotopes / therapeutic use. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Metastasis. Neoplasm Staging. Observation. Prognosis. Proportional Hazards Models. Prospective Studies. Risk Factors. Statistics, Nonparametric. Survival Rate. Thyroidectomy / methods. Ultrasonography

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Endocr Pract. 2006 Jan-Feb;12(1):63-102 [16596732.001]
  • [Cites] World J Surg. 2008 Nov;32(11):2494-502 [18784956.001]
  • [Cites] Cancer. 1975 Sep;36(3):1095-9 [1182663.001]
  • [Cites] World J Surg. 2005 Aug;29(8):1007-11; discussion 1011-2 [15981041.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Jun;91(6):2171-8 [16478817.001]
  • [Cites] Endocr Pract. 2001 May-Jun;7(3):202-20 [11430305.001]
  • [Cites] Ann Surg Oncol. 2009 Feb;16(2):240-5 [19034577.001]
  • [Cites] JAMA. 2006 May 10;295(18):2164-7 [16684987.001]
  • [Cites] Surgery. 2008 Jan;143(1):35-42 [18154931.001]
  • [Cites] Clin Endocrinol (Oxf). 2008 Apr;68(4):599-604 [17986280.001]
  • [Cites] World J Surg. 2004 Nov;28(11):1115-21 [15490053.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Nov;89(11):5362-8 [15531482.001]
  • [Cites] Surgery. 2008 Dec;144(6):980-7; discussion 987-8 [19041007.001]
  • [Cites] Thyroid. 2006 Feb;16(2):109-42 [16420177.001]
  • [Cites] Surgery. 1987 Dec;102(6):1088-95 [3686348.001]
  • [Cites] Cancer. 1981 Jan 15;47(2):319-23 [7459819.001]
  • [Cites] World J Surg. 2004 May;28(5):498-501 [15085396.001]
  • [Cites] Endocr J. 1999 Feb;46(1):209-16 [10426589.001]
  • [Cites] Arch Pathol. 1966 Jun;81(6):531-5 [5934087.001]
  • [Cites] Endocr Pract. 2007 Sep;13(5):498-512 [17872353.001]
  • [Cites] Eur J Surg Oncol. 2006 Dec;32(10):1144-8 [16872798.001]
  • [Cites] Nihon Naibunpi Gakkai Zasshi. 1969 Apr 20;45(1):65-76 [5817904.001]
  • [Cites] Surgery. 2004 Feb;135(2):139-48 [14739848.001]
  • [Cites] Eur J Endocrinol. 2008 Dec;159(6):659-73 [18713843.001]
  • [Cites] Cancer. 2003 Jul 1;98(1):31-40 [12833452.001]
  • [Cites] Surgery. 1998 Dec;124(6):947-57 [9854568.001]
  • [Cites] Cancer. 1970 Jun;25(6):1391-3 [5422914.001]
  • [Cites] Surgery. 1993 Dec;114(6):1050-7; discussion 1057-8 [8256208.001]
  • [Cites] J Surg Oncol. 2007 Jun 1;95(7):555-60 [17226813.001]
  • [Cites] Surgery. 1988 Dec;104(6):947-53 [3194846.001]
  • [Cites] Surgery. 1988 Dec;104(6):971-6 [3194849.001]
  • [Cites] Nat Clin Pract Endocrinol Metab. 2007 Mar;3(3):240-8 [17315032.001]
  • [Cites] World J Surg. 1995 Jul-Aug;19(4):642-6; discussion 646-7 [7676714.001]
  • [Cites] Cancer. 1974 Dec;34(6):2072-6 [4474057.001]
  • [Cites] Thyroid. 2003 Apr;13(4):381-7 [12804106.001]
  • [Cites] Ann Surg. 2003 Mar;237(3):399-407 [12616125.001]
  • [Cites] World J Surg. 1998 Jul;22(7):731-7 [9606290.001]
  • [Cites] Surg Today. 2010 Mar;40(3):199-215 [20180072.001]
  • [Cites] Lancet. 2002 Feb 9;359(9305):520-2 [11853819.001]
  • [Cites] Chir Ital. 2006 Jul-Aug;58(4):441-7 [16999148.001]
  • [Cites] World J Surg. 2008 May;32(5):747-53 [18264828.001]
  • [Cites] Cancer. 2007 Sep 15;110(6):1218-26 [17685465.001]
  • (PMID = 20066418.001).
  • [ISSN] 1432-2323
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Iodine Radioisotopes
  •  go-up   go-down


99. Angouridakis N, Hytiroglou P, Markou K, Bouzakis A, Vital V: Middle ear adenoma/carcinoid tumour: a case report and review of the literature. Rev Laryngol Otol Rhinol (Bord); 2009;130(3):199-202
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Middle ear adenoma/carcinoid tumour: a case report and review of the literature.
  • Middle ear adenoma, a rare benign tumour with glandular and neuroendocrine differentiation, originates from the epithelial lining of the middle ear.
  • Histological examination revealed tumour cells forming gland-like and cribriform structures, as well as compact groups.
  • On immunohistochemical staining, the tumour cells were positive for epithelial (cytokeratins, epithelial membrane antigen) and neuroendocrine (neuron specific enolase, synaptophysin, chromogranin and pancreatic polypeptide) markers.
  • CONCLUSION: Middle ear adenoma is a benign tumour that is treated by complete surgical removal.
  • The immunohistochemical staining of the present case supports the suggestion that this tumour is best described by the term neuroendocrine adenoma of the middle ear.
  • [MeSH-major] Adenoma. Carcinoid Tumor. Ear Neoplasms. Ear, Middle

  • MedlinePlus Health Information. consumer health - Carcinoid Tumors.
  • The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for middle ear adenoma .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20345079.001).
  • [ISSN] 0035-1334
  • [Journal-full-title] Revue de laryngologie - otologie - rhinologie
  • [ISO-abbreviation] Rev Laryngol Otol Rhinol (Bord)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 17
  •  go-up   go-down


100. Withrow KP, Newman JR, Skipper JB, Gleysteen JP, Magnuson JS, Zinn K, Rosenthal EL: Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts. Technol Cancer Res Treat; 2008 Feb;7(1):61-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts.
  • To determine the efficacy of fluorescently labeled anti-vascular endothelial growth factor (VEGF) antibody to be used as a cancer specific optical contrast agent to guide surgical resections, we evaluated the sensitivity and specificity of this agent to detect microscopic residual disease in a preclinical model of head and neck squamous cell carcinoma (HNSCC).
  • Using a flank murine model, mice were xenografted with SCC-1 tumor cells and injected with anti-VEGF antibody (bevacizumab) conjugated to an optically active fluorophore (Cy5.5).
  • Tumors underwent sub-total resections and were assessed for the presence of residual disease by fluorescent stereomicroscopy.
  • Samples taken from a non-fluorescing tumor bed (n=15) were found to be histologically benign in 11 of 15.
  • This data supports previous data presented by this group and supports further investigation of fluorescently labeled anti-tumor antibodies to detect disease in the surgical setting.
  • [MeSH-major] Antibodies, Monoclonal. Carbocyanines. Head and Neck Neoplasms / diagnosis. Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • [MeSH-minor] Animals. Antibodies, Monoclonal, Humanized. Bevacizumab. Humans. Male. Mice. Mice, SCID. Neoplasm Transplantation. Transplantation, Heterologous

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18198926.001).
  • [ISSN] 1533-0346
  • [Journal-full-title] Technology in cancer research & treatment
  • [ISO-abbreviation] Technol. Cancer Res. Treat.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA13148
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / CY5.5 cyanine dye; 0 / Carbocyanines; 0 / Vascular Endothelial Growth Factor A; 2S9ZZM9Q9V / Bevacizumab
  •  go-up   go-down






Advertisement